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TGF-β   transforming growth factor beta 
TNFα   tumor necrosis factor alpha 
UD   undetectable 
VDIPEN   metalloproteinase-induced neo-epitopes of aggrecan 
VEGF   vascular endothelial growth factor 
VLDL   very low-density lipoprotein 
WT   wild type 
  
9 
 
Chapter 1 
 
General introduction 
 
Adapted from 
 
High systemic levels of low-density lipoprotein 
cholesterol: fuel to the flames in inflammatory 
osteoarthritis? 
 
 
Wouter de Munter, Peter M. van der Kraan, Wim B. van den 
Berg and Peter L. E. M. van Lent 
 
Experimental Rheumatology, Radboud University Medical Center, Nijmegen, the 
Netherlands 
 
Rheumatology 2016, 55(1):16-24  
10 
 
Prologue 
Already at the beginning of the last century, osteoarthritis (OA) was seen as a disease in 
which metabolic processes play a role. In 1937, Matthew B. Ray (senior physician of the 
British Red Cross Clinic for Rheumatism) described OA patients as ‘well-nourished 
individuals of a fairly robust type and frequently of a plethoric habit of body’
1
. Fifty years 
earlier, John Kent Spender of the Royal Mineral Water Hospital in Bath, UK, described the 
first stage of OA as the early synovial stage, hinting towards a theory in which synovial 
pathology precedes other OA pathology, such as cartilage damage and osteophyte 
formation
2
. During the 20th century, however, OA was typically seen as a wear-and-tear 
disease, and hardly any research was performed concerning synovial involvement and 
systemic factors. Nevertheless, over the past two decades, the paradigm of OA has been 
shifting from a cartilage-specific disease towards that of an organ disease, in which low-
grade inflammation and systemic pathology do play an important role. Several recent 
reviews discuss the role of (systemic) inflammation in OA
3-5
. In this thesis, we show a role 
specifically for low-density lipoprotein (LDL)-cholesterol in the pathology of inflammatory 
OA.  
Osteoarthritis 
OA is recognized as a disease that affects the whole joint, including subchondral bone, 
ligaments, menisci, periarticular muscle, infrapatellar fat pad, synovial tissue and articular 
cartilage
6,7
. Articular cartilage mainly consists of proteoglycans and collagen type II fibers, in 
which chondrocytes are embedded. Homeostasis of articular cartilage is constantly 
balanced by complex interplay between anabolic and catabolic processes. Failure to 
maintain this balance (by either abnormal loading or abnormal functioning of tissue) lies at 
the base of OA development and is characterized by release of cartilage fragments, 
cytokines and catabolic enzymes that could activate synovial cells and further enhance 
cartilage degradation
7,8
. OA is, however, not confined only to the joint. Serum levels of 
proteins such as collagen type II-associated products, cartilage oligomeric matrix protein 
(COMP), matrix metalloproteinases (MMPs), adipokines and many more have been widely 
studied and shown to be increased in OA patients compared with healthy controls 
(extensively reviewed by Lotz et al.
9
 and Hunter et al.
10
). The Dutch Cohort Hip and Cohort 
Knee (CHECK) study consists of early OA patients (aged between 45 and 65 years) who, on 
entry, had pain or stiffness of the knee or hip. They had not yet consulted their physician 
for these symptoms, or the first appointment occurred within 6 months before cohort 
entry. Even in these early patients, high plasma levels of alarmins S100A8/100A9 (>200 
ng/ml) increased odds of disease progression (odds ratio 4.0) 2–5 years later, whereas high 
erythrocyte sedimentation rate (ESR; up to 31 mm/h) and high levels of C-reactive protein 
11 
 
(CRP; up to 14 ng/l) were not predictive
11
. S100A8 (myeloid-related protein-8) and S100A9 
(myeloid-related protein-14) proteins are produced mainly by granulocytes, monocytes and 
activated macrophages
12-14
. In addition to their function as inflammatory markers
15
, these 
proteins have also been shown to be involved in cartilage damage and synovial activation 
during OA
16,17
.  
Although most of the above-mentioned factors are believed to be the result of, rather than 
causative for, OA-related joint pathology, it suggests that OA is not merely a local disease. 
The fact that basic inflammatory markers, such as ESR and CRP, do not always reflect OA 
pathology might preclude the disease as a common inflammatory disease but does not 
exclude a systemic component. Moreover, there are systemic processes that have been 
shown to increase the risk of primary human OA. Two of these undeniably important risk 
factors are aging and the metabolic syndrome. 
Aging 
Aging could induce OA simply via wear and tear, which means that long-term or excessive 
loading locally increases vulnerability of the joint and, in combination with systemic factors 
that increase susceptibility, such as weight and female sex, cause cartilage damage
18
. Also, 
age could induce OA via chondrocyte senescence. Shortening of telomerase length and 
decrease of mitotic activity in chondrocytes limits the ability of these cells to form new 
cartilage
19
, although this is an unlikely cause of OA in a non-dividing tissue, such as adult 
cartilage. A more recent theory is that, with age, cartilage balance shifts from homeostasis 
towards terminal differentiation
20-23
. Finally, aging also induces low-grade systemic 
inflammation that could influence OA. The word inflamm-aging is often used these days, 
describing a process in which continuous antigen load acts as stressor and eventually 
results in low-grade systemic inflammation
24
. This low-grade inflammation is coupled to 
increased levels of pro-inflammatory factors, such as S100A8 and S100A9, that are also 
important during OA processes
25
.  
Metabolic Syndrome 
A second important risk factor that is described for primary OA is the metabolic 
syndrome
26
. The metabolic syndrome, also known as insulin resistance syndrome or 
metabolic syndrome X, affects ∼22% of the United States population, with a slightly higher 
prevalence in female adults compared with males
27
. The metabolic syndrome includes a 
variety of conditions that, in combination, cause cardiovascular disease and diabetes. These 
conditions are high blood pressure, decreased high-density lipoprotein (HDL) levels, 
increased LDL and triglyceride levels, raised blood glucose levels and abdominal obesity
28
. 
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Obesity has been extensively associated with OA, often leading to the theory that OA is 
induced via a biomechanical link
29
; however, the association of obesity with development 
of OA in non-weight-bearing joints
30-32
 suggests a systemic mechanism, rather than plain 
overloading. This, taken together with studies that report no direct relation between 
obesity and OA
33,34
, supports the recent theory in which the metabolic syndrome, rather 
than obesity itself, is seen as a risk factor for OA
35,36
. Obviously, the metabolic syndrome is 
often accompanied by obesity and, in reality, both mechanisms (overloading and a systemic 
component) will contribute to initiation and aggravation of OA.  
LDLs in OA 
A study by Gierman et al.
37
 showed a relationship between metabolic stress and 
spontaneous development of OA in mice. A high-fat diet increased cartilage damage 
independently of body weight, and this effect could be abolished by lowering cholesterol 
levels, suggesting a cholesterol-mediated mechanism for cartilage damage
37
. In a later 
study, this group also showed that a cholesterol-rich diet in a murine model for 
hyperlipidemia and atherosclerosis led to increased spontaneous cartilage damage, further 
underlining an important role for total cholesterol
38
. In both studies, the authors claim that 
metabolic stress-induced inflammation is more likely to be at the base of cholesterol-
induced cartilage damage than mechanical overload, because anti-inflammatory 
intervention suppressed the development of OA. The evidence that atherosclerosis and OA 
are both associated with the metabolic syndrome and that the cell types that are important 
in the development of atherosclerosis (such as macrophages and endothelial cells)
39
 also 
play an important role in OA pathology
40,41
 suggests that LDL-cholesterol and LDL 
modifications (such as oxLDL) contribute to OA pathology as well.  
One of the features of the metabolic syndrome is increased levels of LDL
42
. In the course of 
metabolic syndrome, high levels of non-esterified fatty acids, together with 
hyperinsulinemia and low adiponectin levels, provide substrate for increased production of 
very low density lipoprotein (VLDL) in the liver. VLDL, with its associated apolipoprotein B 
(APOB), is converted to LDL particles, which form the main transport vehicle of cholesterol 
from the liver to all other cells in the body. Normally, HDL particles reverse cholesterol 
transport; however, the metabolic syndrome is characterized by low levels of HDL, thus 
resulting in increased LDL levels
43
. LDL is internalized by cells via the LDL receptor (LDLR), 
where it releases its cholesterol after lysosomal hydrolysis. Cholesterol is an essential 
component of the plasma membrane, serving a barrier function, modulating fluidity and 
forming lipid rafts
44
. After taking up LDL, LDLR expression by the cell is decreased, blocking 
further uptake of LDL and efficiently regulating intracellular cholesterol levels
45,46
. As a 
result of this regulated LDL uptake by cells and low levels of HDL, the serum levels of LDL 
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remain high in patients with the metabolic syndrome. Although LDL has been extensively 
studied in the pathology of cardiovascular diseases
47,48
, it has gained relatively little 
attention in clinical OA research. Comparative analysis of serological parameters has 
demonstrated that OA patients have significantly higher serum LDL levels compared with 
age-, sex- and BMI-matched healthy controls
49,50
.  
Oxidation of LDL and its effects on cellular level 
A variety of factors have been proposed to induce LDL oxidation [e.g. sphingomyelinase, 
reactive oxygen species (ROS), secretory phospholipase-2, other lipases and MPO]. 
Although the precise mechanism by which LDL is oxidized in vivo is unknown, ROS is 
generally seen as the main suspect
51-53
. OxLDL can be taken up by endothelial cells, 
fibroblasts and macrophages, among others, via scavenger receptors (SR) such as SR-A
54
, 
CD36 (SR-B)
55
 and lectin-type oxLDL receptor 1 (LOX-1; SR-E)
56,57
. As these receptors lack 
the self-regulating mechanism of LDLR, high levels of oxLDL could have far-reaching effects 
on the cells that take up these molecules. Different cell types have been described to 
respond upon oxLDL uptake. Fibroblast stimulation by oxLDL is mainly mediated via LOX-1, 
inducing production of MMP-1 and MMP-3
58
. Also, endothelial cells can be activated by 
oxLDL via LOX-1, resulting in increased expression of leukocyte adhesion molecules and 
enhanced secretion of chemoattractants such as chemokine (C-C motive) ligand 2 [CCL2, 
also referred to as monocyte chemotactic protein 1(MCP-1)]
59
. Mostly described, however, 
is oxLDL uptake by macrophages via SR-A and CD36. A review by Maiolino et al.
60
 
thoroughly discusses the role of oxLDL uptake by macrophages and the different effects on 
inflammation. Uptake of oxLDL by macrophages causes production of pro-inflammatory 
mediators such as IL-6, IL-8, MCP-1 and S100A8/9
61,62
, matrix-degrading proteinases MMP-
1 and MMP-3
63
 and growth factors such as TGF-β
61
. Very recently, Hossain et al.
64
 also 
reported that LOX-1, which is normally expressed in relatively low levels on macrophages, 
potentially plays an important role in oxLDL uptake by macrophages. Toll-like receptor 4-
stimulation strongly up-regulates surface expression of LOX-1 in macrophages, resulting in 
elevated oxLDL uptake.  
In addition to synovial cells, it has also been described that chondrocytes exhibit LOX-1 
receptors
65,66
. Stimulation of chondrocytes by oxLDL results in intracellular ROS 
production
67
, mediates intracellular MMP-3 accumulation and secretion
68
 and up-regulates 
mRNA levels of VEGF and mRNA and protein levels of MCP-1
69,70
 (figure, mechanism A). 
Furthermore, Kishimoto et al.
71
 show that bovine chondrocytes, cultured with oxLDL, 
increase expression of runt-related transcription factor 2, resulting in hypertrophic, type X 
collagen-producing chondrocytes, thereby suggesting a possible molecular mechanism by 
which oxLDL could lead to terminal chondrocyte differentiation and cartilage destruction. 
14 
 
Nevertheless, studies investigating the effect of oxLDL directly on chondrocytes are scarce 
and are confined to in vitro experiments.  
Oxidized LDL as a potential inducer of OA pathology 
Given that the same cells that have been described as being affected by oxLDL in 
cardiovascular diseases, such as macrophages, endothelial cells and fibroblasts, are 
dominant cells within synovium, we postulate that oxLDL can play an important role in OA 
pathology. A substantial population of OA patients develops synovitis, in which cells such as 
synovial macrophages are suggested to play a key role
3,40,72-74
. OxLDL could therefore be a 
strong modulator of OA pathology. The figure depicts a putative pathway showing how 
oxLDL influences OA pathology via activation of synovial cells. Increased levels of oxLDL 
activate synovial cells such as macrophages, fibroblasts and endothelial cells via SRs (figure, 
mechanism B). These cells are than able to produce inflammatory and chemotactic factors, 
stimulating monocyte influx and resulting in aggravated inflammation (figure, mechanism 
C)
58,59,62,63
.  
 
Hypothesized mechanism for aggravation of OA pathology by oxidized low-density lipoprotein 
(A) OxLDL stimulation of chondrocytes results in MMP-3 secretion, COL10 production and increased 
mRNA expression of ROS, Runx2 and VEGF. (B) Moreover, LDL-cholesterol can be oxidized during 
inflammatory OA, leading to activation of synovial macrophages and endothelial cells. (C) These cells 
start to produce inflammatory and chemotactic factors, stimulating monocyte influx and resulting in 
aggravated inflammation. (D) Additionally, oxLDL can stimulate fibroblasts to produce catabolic 
enzymes and macrophages to produce growth factors such as TGF-β. 
15 
 
In mice, increased accumulation of modified LDL in synovium is associated with increased 
production of S100A8 and S100A9
61
. Additionally, oxLDL could stimulate synovial fibroblasts 
to produce catabolic enzymes, as described by Ishikawa et al.
58
 and stimulate lining 
macrophages to produce growth factors such as TGF-β
61
 (figure, mechanism D). These 
processes could then aggravate synovial inflammation, cartilage destruction and ectopic 
bone formation, eventually increasing oxidative stress and resulting in a vicious cycle of 
increased OA pathology. 
Treatment 
Much is still unknown about the exact role of oxLDL in inflammatory OA; nevertheless, 
involvement of oxLDL in OA pathology stands to reason. This creates new opportunities for 
possible therapies. To date, no drug has been consistently found to have modifying effects 
on the structural progression of OA. While cytokine targeting has been shown to be an 
effective treatment in RA, there is little evidence that this is also the case in OA. Studies 
focusing on biologics in OA, such as anti-IL-1
75-82
 and anti-TNF
83,84
, show no convincing 
therapeutic effects. Hence, current therapies (predominantly involving analgesics and 
NSAIDs) focus merely on symptomatic relief
85
. More insight into OA progression, and the 
possible role of (ox)LDL, may provide new leads for effective therapies.  
Considering a role for LDL-cholesterol in the development of OA, the use of statins would 
be one of the most obvious therapies. Statins lower cholesterol biosynthesis and thus 
systemic levels of LDL. In mice, the statin atorvastatin (lowering cholesterol biosynthesis) 
could diminish the severity of OA in cholesterol-induced joint pathology, whereas the total-
cholesterol-lowering non-statin ezetimibe (limited to inhibiting cholesterol uptake in the 
intestine) could not
38
. Given that it has been described that statins, in addition to 
specifically lower serum LDL levels, also reduce development of atherosclerosis by 
modulating oxLDL-mediated pathology
86,87
, the theory arises that specifically LDL-
cholesterol and LDL modifications (such as oxLDL) play a role in OA pathology. Interestingly, 
another study by the same group showed no effect on cartilage destruction by the statin 
simvastatin in the spontaneous OA model in SRT/Ort mice
88
. It is important to mention, 
however, that these specific STR/Ort mice display abnormal lipidemic symptoms that could 
interfere with statin treatment
89
. Also, several other in vivo animal studies show beneficial 
effects of statins on cartilage degradation in animal OA models
90,91
; however, evidence of 
beneficial effects in human OA is scarce
92
. A Dutch prospective population-based cohort 
study
93
 and two studies from the UK
94,95
 show positive effects of statins, whereas two 
studies from the USA do not show beneficial effects
96,97
. The controversies regarding statin 
use as a treatment for OA could be explained by the assumption that, besides high LDL-
16 
 
cholesterol levels, specific oxidative triggers also play a role in OA pathology; emphasizing 
that high LDL levels alone are not enough to induce/aggravate OA without oxidation.  
Perhaps combining statin treatment with antioxidants could result in decreased OA 
morbidity; however, even in atherosclerosis, where oxLDL involvement is apparent, a 
beneficial role for antioxidants has not been proved
98,99
.  
More insight in the mechanism by which oxLDL leads to joint pathology might lead to 
better options. For example, blocking uptake of oxLDL by specific synovial cells could 
prevent progression of OA. 
Aim and outline of this thesis 
Despite the vast amount of knowledge about the role of LDL in the pathology of 
cardiovascular diseases, it has gained little attention in clinical OA research. The aim of this 
thesis was to elucidate the role of LDL-cholesterol, and specifically oxidized LDL-cholesterol, 
in OA pathology. 
We first investigated whether increased systemic levels of LDL can aggravate three main 
OA-features, that is inflammation, cartilage damage and ectopic bone formation (Chapter 
2). We therefore injected collagenase into the murine knee joints of WT mice and mice 
deficient for the LDL-receptor (Ldlr
-/-
). Collagenase causes damage to ligaments, resulting in 
destabilization of the joint. This will then lead to an inflammatory experimental 
osteoarthritis. Alongside genetically-induced high levels of LDL, we also used a cholesterol-
rich diet to increase systemic cholesterol levels, both not affecting body weight. 
In Chapter 3, we studied the relation between S100A8/A9-induced inflammation and 
ectopic bone formation, two processes we found to be induced by high LDL levels during 
OA in chapter 2. In this chapter we used S100a9
-/-
 mice, which functionally also lack 
extracellular S100A8, in order to investigate the role of S100 proteins in ectopic bone 
formation. We used two different OA models: collagenase-induced OA (CiOA) and OA by 
destabilization of the medial meniscus (DMM). In the CiOA model synovial activation is 
pronounced and involved in the pathogenesis of the disease, while the DMM model has 
considerably lower synovitis. Furthermore, we investigated chondrogenesis in vitro and 
coupled systemic S100A8/A9 levels of early symptomatic OA patients to ectopic bone 
formation up till five years later. For that, we obtained plasma from patients who 
participated in the Dutch Cohort Heup en Cohort Knie (CHECK) study. 
Chapter 4 focuses on another model for systemic high levels of cholesterol. We first 
confirmed our previous findings that high cholesterol levels induce OA pathology (chapter 
2), now using apolipoprotein E-deficient (Apoe
-/-
) mice. A mouse strain that develops even 
17 
 
higher LDL levels compared with the earlier used Ldlr
-/-
 mice. Since previous chapters 
taught us that high cholesterol (chapter 2) and S100A8/A9 (chapter 3) could aggravate OA 
pathology, we additionally studied here whether these processes are linked and what the 
causality is between them using mice deficient for both S100A9 and APOE. We used gene 
expression and protein levels of chemokine (C-X-C motif) ligand 1 (also known as 
keratinocyte chemoattractant) as a marker for joint inflammation and used digital histology 
analysis to determine the amount of ectopic bone formation. 
While previous chapters described how a combination of systemically and locally high 
cholesterol levels affect OA, we, in Chapter 5, focused on the pathology that oxLDL directly 
induces locally in the joint. We started off by confirming the presence of APOB (the main 
protein present in LDL and oxLDL) in human OA synovium. Subsequently, we injected 
oxLDL, LDL, or PBS (vehicle) intraarticularly (injections underneath the patella, directly into 
the joint cavity; i.a.) in murine knee joints. Furthermore, we studied the role of synovial 
macrophages in the observed pathology, using i.a. injections of clodronate liposomes to 
deplete synovial lining macrophages from the joint. The novelty of this chapter is that we 
also focused on the type of immune cells that are involved in joint pathology, using specific 
immunohistochemical staining and flow cytometry. 
In this thesis we specifically focused on LDL and its oxidized form, but there are more ways 
in which components of the cholesterol metabolic pathway could affect OA development. 
While in chapter 4 APOE-deficiency was merely a tool to increase systemic LDL levels, there 
are also other functions described for this protein that are unrelated to lipoprotein 
transport. In humans there are three isoforms of APOE, namely APOε2, APOε3 and APOε4. 
It has been shown that APOE has anti-inflammatory effects on macrophages and that the 
extent of this effect depends on the isoform of the molecule (APOε2>APOε3>APOε4).
100
 
We, therefore, dedicated this short chapter (Chapter 6) to the possibility of APOE-
polymorphisms to affect OA pathology. We induced CiOA in mice of which the murine 
APOE gene is replaced by the human APOε3 or APOε4 gene and investigated pathology. 
In the final chapter (Chapter 7) we summarized and discussed the results of this thesis and 
offered future perspectives. 
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Abstract 
Introduction 
Osteoarthritis (OA) is associated with the metabolic syndrome, however the underlying 
mechanisms remain unclear. We investigated whether low density lipoprotein (LDL) 
accumulation leads to increased LDL uptake by synovial macrophages and affects synovial 
activation, cartilage destruction and enthesophyte/osteophyte formation during 
experimental OA in mice.  
Methods 
LDL receptor deficient (Ldlr
-/-
) mice and wild type (WT) controls received a cholesterol-rich 
or control diet for 120 days. Experimental OA was induced by intra-articular injection of 
collagenase twelve weeks after start of the diet. OA knee joints and synovial wash-outs 
were analyzed for OA-related changes. Murine bone marrow derived macrophages were 
stimulated with oxidized LDL (oxLDL), whereupon growth factor presence and gene 
expression were analyzed.  
Results 
A cholesterol-rich diet increased apolipoprotein B (APOB) accumulation in synovial 
macrophages. Although increased LDL levels did not enhance thickening of the synovial 
lining, S100A8 expression within macrophages was increased in WT mice after receiving a 
cholesterol-rich diet, reflecting an elevated activation status. Both a cholesterol-rich diet 
and LDLR-deficiency had no effect on cartilage damage; in contrast, ectopic bone formation 
was increased within joint ligaments (fold increase 6.7 and 6.1, respectively). Moreover, 
increased osteophyte size was found at the margins of the tibial plateau (4.4 fold increase 
after a cholesterol-rich diet and 5.3 fold increase in Ldlr
-/-
 mice). Synovial wash-outs of Ldlr
-/-
 
mice and supernatants of macrophages stimulated with oxLDL led to increased 
transforming growth factor-beta (TGF-β) signaling compared to controls.  
Conclusions 
LDL accumulation within synovial lining cells leads to increased activation of synovium and 
osteophyte formation in experimental OA. OxLDL uptake by macrophages activates growth 
factors of the TGF-superfamily. 
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Introduction 
Osteoarthritis (OA) is a common disease of unknown etiology. The association of OA with 
metabolic syndrome has long been established but the exact mechanism remains 
unclear
1,2
. The idea that obesity enhances OA development solely due to increased loading
3
 
is obsolete and more often studies show the association between obesity and OA 
development in non-weight-bearing joints
4-7
.  
Decreased levels of high-density lipoprotein (HDL) and increased levels of low-density 
lipoprotein (LDL) particles are, amongst other features, part of the metabolic syndrome
8
. In 
a comparative analysis of serological parameters, several studies demonstrated that OA 
patients have significantly higher serum levels of LDL compared to healthy controls
9,10
. 
Studies focusing on cardiovascular diseases, such as atherosclerosis, show pro-
inflammatory capacities of LDL and modified LDL
11,12
. LDL particles form the main transport 
vehicle of cholesterol from the liver to the tissues. LDL can be oxidized in an inflammatory 
milieu and, therefore, high levels of LDL result in enhanced oxidized LDL (oxLDL) levels in 
pathological conditions where free radicals are present
13,14
. OxLDL is taken up by 
macrophages via scavenger receptor class A, B (CD36) and E (lectin-like oxLDL receptor-1; 
LOX-1), resulting in a phenotype shift into a more inflammatory cell type
15-19
.  
A substantial population of OA patients develops a thickened lining layer comprising 
macrophages that exhibit an activated phenotype. Macrophages derived from biopsies with 
early OA produce elevated amounts of pro-inflammatory mediators
20
. Depletion of 
macrophages from OA synovium using anti-CD14–conjugated magnetic beads led to 
decreased levels of TNF-α, IL-1β, IL-6 and IL-8
21
. In previous studies we have shown that 
synovial macrophages are crucial in the development of joint pathology in experimental 
OA. Selective depletion of lining macrophages using the clodronate-suicide technique prior 
to induction of collagenase-induced OA strongly inhibited development of cartilage 
destruction and osteophyte formation, probably regulated by a strong decrease in 
metalloproteinase (MMP)-3 and -9 expression
22
.  
Transforming growth factor-β (TGF-β) and bone morphogenetic proteins (BMP) are 
important growth factors involved in the formation of new cartilage or bone in ligaments 
(enthesophyte formation) or along the bone surface (ectopic bone formation or osteophyte 
formation)
23
. In previous studies we showed that multiple injections of members of the 
TGF-super family, such as TGF-β or BMP-2, directly into the knee joint of the mouse caused 
abundant enthesophyte/osteophyte formation
24,25
. Moreover, we postulated that local 
depletion of synovial macrophages prior to injections of these growth factors significantly 
inhibited new formation of cartilage/bone, suggesting that macrophage factors highly 
contribute to this process
26,27
.  
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The presence of high levels of LDL in OA joints with an enhanced inflammatory 
environment may lead to uptake of oxLDL by synovial lining macrophages, thereby 
contributing to development of OA pathology. LDL receptor deficient (Ldlr
-/-
) mice, which 
are generally used in atherosclerotic research
28
, are unable to clear and metabolize 
cholesterol-rich intermediate and low density lipoproteins, causing hypercholesterolemia 
that can be enhanced by a cholesterol-rich diet
29
. In this study, we investigated the effect 
of increased serum LDL levels on OA development in experimental collagenase-induced OA. 
We focused on synovial thickening/activation, cartilage damage and 
enthesophyte/osteophyte formation in both Ldlr
-/-
 mice and mice receiving a cholesterol-
rich diet. 
Methods 
Animals 
Female mice homozygous for the Ldlr
tm1Her
 mutation (Ldlr
-/-
) and their wild type (WT) 
control C57BL/6 J were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). Mice 
were 10 to 13 weeks old when used in the experiments, were housed in filter-top cages 
and received food and water ad libitum. Animal studies were approved by the Institutional 
Review Board (Animal Experiment Committee Radboud University Medical Center) and 
were performed according to the related codes of practice.  
Collagenase-induced osteoarthritis 
Mice were fed a standard diet or a cholesterol-rich diet (+0.15% cholesterol; AB Diets, 
Woerden, the Netherlands). Instability OA was induced by intra-articular injection of 1 unit 
bacterial collagenase (Sigma-Aldrich, St. Louis, MO, USA) into the right knee on days 84 and 
86 after start of the diet
30
. On day 120, mice were weighed and sacrificed, after which both 
left and right knee joints were isolated and processed for histological analysis. Serum 
samples were obtained to determine cholesterol levels.  
Histological and immunohistochemical preparation 
Isolated knee joints were fixed in 4% buffered formalin and subsequently decalcified in 
formic acid and embedded in paraffin. Eight representative sections (7 μm) of each joint 
from various depths were stained with H & E or Safranin O-fast green for histological 
analysis. For immunohistochemistry, sections were deparaffinized and endogenous 
peroxidase activity was blocked using 1% H2O2 in methanol. Next, sections were incubated 
in buffered citrate (pH 6.0) for antigen retrieval. Incubation with 0.1% Triton X-100 was 
used for cell membrane permeabilization, followed by incubation with rabbit anti-mouse 
apolipoprotein B (APOB; Abcam, Cambridge, UK), rabbit anti-mouse S100A8 (kindly 
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provided by Dr. Vogl, Institute of Immunology, University of Muenster, Germany), or 
normal rabbit immunoglobulin G (IgG) (R&D Systems, Minneapolis, MN, USA) as control. 
Subsequently, sections were incubated with the secondary antibody, biotinylated goat anti-
rabbit IgG, and binding was detected using the ABC-HRP kit (Elite kit; Vector Laboratories, 
Burlingame, CA, USA). Peroxidase was developed with diaminobenzidine (DAB; Sigma-
Aldrich) and sections were counter-stained with hematoxylin. Sections were randomly 
coded and scored in a blinded way by two independent investigators.  
Histological analysis 
Synovial thickening and immunohistochemical staining were measured using an arbitrary 
scoring system (0 to 3, where 0 = no thickening/staining and 3 = most observed 
thickening/staining). Three sections of various depths were scored per knee joint.  
Cartilage damage in the tibial-femoral joint was scored using the OA score developed by 
Pritzker et al.
31
, adapted by us for mice (from 0 = no damage, to 30 = maximal damage). Five 
sections were scored per knee joint.  
Size of ectopic bone formation was measured by the use of image analysis (Leica Qwin, 
Leica Microsystems, Rijswijk, The Netherlands). Osteophytes and enthesophytes were 
manually circled by an investigator blinded for the experimental condition, after which the 
surface areas were calculated by Leica-software. The mean cross-sectional surface area in 
three sections per knee joint was determined, including knee joints without ectopic bone 
formation.  
Synovial wash-outs 
Synovium was isolated from murine knee joints 7 and 36 days after collagenase injection. 
Tissue was weighed and put in Roswell Park Memorial Institute medium (RPMI; Gibco, 
Invitrogen, Carlsbad, CA, USA), enriched with 48 μg/mL gentamicin (Centrafarm, Etten-Leur, 
The Netherlands) and 0.1% BSA (Sigma-Aldrich) for one hour at room temperature.  
Bone marrow derived macrophages 
Macrophages were differentiated out of bone marrow cells using 15 ng/mL recombinant 
murine macrophage colony stimulating factor (M-CSF; R&D Systems). For this, tibiae from 
WT or Ldlr
-/-
 mice were removed and bone marrow cells were flushed with DMEM; Gibco) 
supplemented with 10% FCS (Thermo Scientific, Waltham, MA, USA), 1 mM pyruvate 
(Gibco) and 48 μg/mL gentamicin.  
Oxidized LDL preparation and macrophage stimulation 
OxLDL was prepared from a large batch of LDL which was first isolated by single-spin 
density-gradient ultracentrifugation from ethylenediaminetetraacetic acid (EDTA)-treated 
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blood donated by healthy volunteers and frozen in 10 mM phosphate buffer (pH 7.4) 
containing 0.9% NaCl, 10% (w/v) saccharose and 0.1 mM EDTA. LDL was thawed and 
dialyzed for seven hours against saline in a Slide-A-Lyzer cassette (Pierce Chemical 
Company, Rockford, IL, USA). Subsequently, LDL was oxidized with 0.5 mg/mL copper 
sulfate (Merck, Darmstadt, Germany) for 24 hours at room temperature, after which oxLDL 
was dialyzed again for one hour
32
. OxLDL concentration was determined by the use of a 
bicinchoninic acid assay (Thermo Scientific) and a Sunrise microplate reader (Tecan Group, 
Männedorf, Switzerland). OxLDL was pre-incubated for 10 minutes with 10 μg/mL 
polymixine B sulfate (Sigma-Aldrich) before experimental use in order to rule out 
lipopolysaccharide (LPS) interference. Macrophages were stimulated with 50 μg/mL oxLDL, 
or an equal volume of saline (also pre-incubated with 10 μg/mL polymixine B sulfate) for 24 
or 48 hours at 37°C. Stimulations were performed in 5% non heat-inactivated FCS. 
Supernatant was used for functional TGF-β and BMP analyses and cells were lysed in 500 μL 
TRI-reagent (Sigma-Aldrich) for quantitative detection of messenger RNA levels. All 
reactions were performed in quadruple.  
Quantitative real-time polymerase chain reaction 
RNA was extracted using the single step RNA isolation method described by Chomczynski 
and Sacchi
33
. Isopropanol (Merck) was used for precipitation, after which the RNA pellet 
was washed twice with 75% ethanol. The pellet was reconstituted in RNAse free water and 
subsequently treated with DNase (Invitrogen). RNA was reversed transcribed into 
complementary DNA (cDNA) using reverse transcriptase, oligo(dT) primers and dNTPs 
(Invitrogen).  
Quantitative real-time PCR (qPCR) was performed using StepOnePlus Real-Time PCR system 
and StepOne software v2.2 (Applied Biosystems, Foster City, CA, USA), under the following 
conditions: 10 minutes 95°C, followed by 40 cycles of 15 seconds 95°C and 1 minute 60°C. 
Data were collected during the last 30 seconds of each cycle. Product specificity was 
confirmed by assessment of dissociation-characteristics. The reaction was performed in a 
total volume of 10 μL, containing 3 μL diluted cDNA, 1 μL forward primer (5 μM), 1 μL 
reverse primer (5 μM) and 5 μL SYBR Green Master Mix (Applied Biosystems). The following 
primers were designed with Primer Express 2.0 (Applied Biosystems) and manufactured by 
Biolegio (Nijmegen, the Netherlands): mGapdh: 5′-GGCAAATTCAACGGCACA-3′ (forward) 
and 5′-GTTAGTGGGGTCTCGCTCCTG-3′ (reverse); mIl-12p40: 5′-
AGCTAACCATCTCCTGGTTTGC-3′ (forward) and 5′-CCACCTCTACAACATAAACGTCTTTC-3′ 
(reverse); mTgfb1: 5′-GCAGTGGCTGAACCAAGGA-′3 (forward) and 5′-
AAGAGCAGTGAGCGCTGAATC-3′ (reverse); mBmp2: 5′-CGCAGCTTCCATCAC-3′ (forward) and 
5′-GCCGGGCCGTTTTCC-3′ (reverse); mBmp4: 5′-CCGCTTCTGCAGGAACCA-3′ (forward) and 
5′-AGTGCGTCGCTCCGAATG-3′ (reverse); mBmp7: 5′-ACGGACAGGGCTTCTCCT-3′ (forward) 
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and 5′-ATGGTGGTATCGAGGGTG-3′ (reverse). Relative expression levels were presented as 
ΔΔCt, being the threshold cycle (Ct) value corrected for Gapdh and unstimulated control.  
CAGA-Luc and BRE-Luc reporter constructs 
3T3 cells (ATCC, Manassas, VA, USA) were transduced with a CAGA-Luciferase reporter 
plasmid (CAGA-Luc) or a BMP responsive-luciferace reporter plasmid (BRE-Luc) for two and 
a half hours with a multiplicity of infection of 10. Both plasmids were kindly provided by Dr. 
Ten Dijke (Department of Molecular Cell Biology, Leiden University Medical Center, the 
Netherlands). After 24 hours, the transduction efficiency of CAGA-Luc was checked with 
fluorescence microscopy, confirming the presence of GFP that is constitutively active in this 
construct. The transduced cells were then stimulated overnight with macrophage 
supernatant or synovial wash-outs under serum-free conditions, after which luminescence 
was measured.  
Statistical analysis 
Statistical differences between two values were calculated using a student’s t-test or Mann 
Whitney U test depending on Gaussian distribution. Statistical differences between more 
than two values were tested using a one-way analysis of variance (ANOVA) or Kruskal-Wallis 
test, followed by a Bonferoni or Dunns post test, respectively. All analyses were performed 
using Graph Pad Prism 5 (GraphPad Software, La Jolla, CA, USA) and P-values less than 0.05 
were considered to be significant. Data are depicted as mean ± standard error of the mean 
(SEM).  
Results 
A cholesterol-rich diet increased serum cholesterol levels and enhanced APOB uptake by LDLR-
deficient synovial lining cells  
To investigate the effects of enhanced serum cholesterol levels during pathogenesis of 
experimental collagenase-induced OA, both WT and Ldlr
-/-
 mice were fed a standard diet or 
cholesterol-rich diet for 120 days. A cholesterol-rich diet resulted in a 21% increase of body 
weight in WT mice (from 23.8 g ± 0.4 to 28.8 g ± 1.5; P = 0.05), but, in contrast, did not 
significantly affect the weight of Ldlr
-/-
 mice (Figure 1A). Serum analysis for cholesterol 
levels showed that a cholesterol-rich diet in WT mice increased serum LDL concentration by 
128% (from 0.54 mmol/L ± 0.04 to 1.23 mmol/L ± 0.13; P = 0.006). In LDLR-deficient mice, 
enhanced serum LDL concentration following a cholesterol-rich diet was even more 
pronounced (428% raise, from 7.33 mmol/L ± 0.46 to 38.73 mmol/L ± 3.11; P<0.0001; Figure 
1B). Apart from enhanced serum LDL levels, local effects of a cholesterol-rich diet and 
LDLR-deficiency were also investigated. Expression of APOB, which is the main protein in 
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oxLDL particles, was examined by immunohistochemistry. Both a cholesterol-rich diet and 
LDLR-deficiency enhanced uptake of APOB by the synovium. Particularly, cells in the lining 
layer accumulated APOB within their cytoplasm. Mice deficient for the LDLR showed a 
significant increase in APOB staining after receiving a cholesterol-rich diet, suggesting 
enhanced up-take of oxLDL (Figure 1C). 
 
FIG 1. A cholesterol-rich diet leads to increased serum LDL levels and apoB accumulation in synovial 
lining  
Both WT and LDLr deficient mice received a normal or cholesterol-rich diet for 120 days. Increased 
body weight following a cholesterol-rich diet was observed in WT mice but not in LDLr deficient mice 
(A). Serum LDL levels were increased both in WT and LDLr deficient animals after receiving a 
cholesterol-rich diet (B). Synovial lining cells (predominantly macrophages) of LDLr deficient mice 
showed increased intracellular apoB accumulation, suggesting increased oxLDL uptake (C). *P<0.05; 
***P<0.001 versus WT mice with normal diet; ‡P<0.001 versus LDLr deficient mice with normal diet 
and WT mice with cholesterol-rich diet. n = 10 mice per group. 
A B 
C 
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FIG 2. Cholesterol-rich conditions lead to an activated synovium, rather than synovial thickening 
Thickening of the synovial lining layer was determined in hematoxylin and eosine stained sections, 
using an arbitrary score between 0 and 3. All mice showed moderate synovial thickening with no 
significant differences between various groups (A). Immunohistochemistry, however, showed an 
increase in S100A8 expression in WT mice after receiving a cholesterol rich diet, suggesting enhanced 
macrophage activation (B). *P<0.05. n = 10 mice per group. 
A 
B 
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These results suggest a positive relation between oxLDL accumulation by lining 
macrophages and serum LDL levels. 
High serum cholesterol levels did not alter synovial thickening but increased the activation 
status of the macrophage particularly in wild type mice during collagenase-induced 
osteoarthritis  
Since high serum levels of LDL resulted in enhanced uptake of (modified) LDL by the 
synovial lining layer cells, we further investigated whether enhanced serum LDL levels 
during collagenase-induced experimental OA affected synovial thickening. Histology of knee 
joints at day 36 after induction of experimental OA showed moderate synovial thickening in 
WT mice on a normal diet (1.4 ± 0.2; Figure 2A). Synovial thickness, however, was not 
significantly higher in mice that received a cholesterol-rich diet, nor was it significantly 
higher in mice deficient for the LDL receptor. To study the contribution of the macrophage 
to lining layer activation, immunostaining with S100A8 was performed. S100A8 is expressed 
only by activated macrophages but not by fibroblasts
34
. WT mice showed an increased 
S100A8 expression after receiving a cholesterol-rich diet (from 0.43 ± 0.16 to 1.13 ± 0.35; 
P = 0.035). In Ldlr
-/-
 mice increased S100A8 expression after a cholesterol-rich diet did not 
reach significance Figure 2B).  
High serum cholesterol levels caused by a cholesterol-rich diet did not alter cartilage 
destruction in collagenase-induced osteoarthritis  
Since we show that a cholesterol-rich diet is capable of activating macrophages, we further 
investigated whether high serum cholesterol levels affect cartilage damage. Overall 
cartilage destruction was mild (mean score WT mice without cholesterol-rich diet 6.1 ± 1.5; 
Figure 3). Although WT mice that received a cholesterol-rich diet showed marginal 
differences in cartilage damage compared to mice receiving a normal diet at the lateral side 
of the femur and both lateral and medial side of the tibia, these values did not reach 
significance. In line with this, no differences in cartilage damage were seen in LDLR-
deficient mice between the group receiving the normal diet and the group receiving the 
cholesterol-rich diet. Moreover, no differences between cartilage damage in WT mice on 
the normal diet and LDLR-deficient mice on the normal diet were observed (Figure 3). 
Increased serum cholesterol levels result in enhanced bone formation in ligaments during 
experimental osteoarthritis  
Earlier studies have shown that synovial macrophages are crucial in mediating new 
formation cartilage/bone in ligaments and along the bone surface. Since formation of 
enthesophytes are a consistent and early feature of OA
35
, leading to ligament rigidity and 
less functionality of the joint, we first examined the effects of high cholesterol levels on 
ectopic bone formation in collateral and cruciate ligaments. 
33 
 
 
FIG 3. Increased serum cholesterol levels do not affect cartilage damage during experimental OA 
Cartilage damage was scored at the medial and lateral side of the tibial plateau and femoral condyles 
(A). No significant differences were found between the different groups. B shows representative 
pictures (stained with safranin O - fast green) of the medial femoral condyle and tibial plateau of four 
OA joints. Two representative pictures of naïve joints show that the observed cartilage damage was 
due to collagenase injection rather than age or genomic and environmental factors. ns = not 
significant. n = 10 mice per group. 
 
While only four out of ten WT mice with OA on a normal diet showed enthesophyte 
formation, there were eight out of ten WT mice on a cholesterol-rich diet that presented 
enthesophyte formation. In LDLR-deficient mice on a normal diet, eight out of ten mice 
showed enthesophyte formation, whereas there were nine out of ten mice in the LDLR-
A 
B 
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deficient group on a cholesterol-rich diet that showed this condition (Figure 4A). Both a 
cholesterol-rich diet and LDLR-deficiency resulted in a significantly increased size of 
enthesophytes (fold increase of 6.7 and 6.1, respectively; P<0.05). In contrast, the 
combination of Ldlr
-/-
 and a cholesterol-rich diet only showed a trend towards an increased 
total size of enthesophytes compared to WT mice on a normal diet; however, values did 
not reach significance (Figure 4B and C). 
High serum cholesterol levels result in increased osteophyte formation and presence of active 
TGF-β in collagenase-induced osteoarthritis  
Since enthesophyte formation in joint ligaments strongly correlates with osteophyte 
formation
23
, we next investigated whether serum cholesterol levels affected osteophyte 
formation. We measured osteophyte size at the margins of the lateral and medial side of 
the tibial plateau and femoral condyles using image analysis. LDLR-deficient mice, receiving 
a cholesterol-rich diet, showed significant enhancement of osteophyte formation at the 
lateral side of the tibial plateau, when compared to WT mice with a cholesterol-rich diet 
(fold increase 2.7; P<0.01). Even more pronounced was the increase in osteophyte 
formation in LDLR-deficient mice on a normal diet, compared to WT mice on the same diet 
(fold increase 5.3; P<0.001; Figure 5A and B). Besides increased osteophyte formation due 
to LDLR-deficiency, a cholesterol-rich diet further increased osteophyte formation at the 
lateral site of the tibial plateau in LDLR-deficient mice (fold increase 1.8; P<0.05). At the 
medial side of the tibia, a cholesterol-rich diet resulted in increased osteophyte formation 
in WT mice (fold increase 4.4; P<0.01). Thus, both a cholesterol-rich diet and LDLR-
deficiency cause increased osteophyte formation at the margins of the tibial plateau. At the 
margins of the femoral condyles, no significant differences in osteophyte formation were 
found between the various groups (data not shown). In previous studies we have shown 
that TGF-β and BMPs are major growth factors involved in driving new formation of 
cartilage/bone
24,25
. We therefore tested synovial wash-outs of WT and Ldlr
-/-
 mice for the 
presence of active TGF-β using a CAGA-Luc assay (Figure 5C). Both on the 7
th
 and 36
th
 day 
after collagenase injection, levels of activated TGF-β were significantly higher in Ldlr
-/-
 mice 
on a cholesterol-rich diet, compared to WT mice on a cholesterol-rich diet. 
OxLDL stimulated macrophages activate TGF-β in vitro 
As APOB-accumulation in synovial macrophages correlated with increased ectopic bone 
formation in both WT and Ldlr
-/-
 mice, we investigated whether oxLDL stimulated 
macrophages are capable of producing anabolic factors that may be responsible for this 
process.  
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FIG 4. Enhanced serum cholesterol levels increase ectopic bone formation in ligaments 
The size of cartilage and bone formations was measured using digital image analysis. The incidence of 
ectopic bone formation was increased after a cholesterol-rich diet, LDL receptor deficiency and the 
combination of these two (A). The photographs depict representative examples of ectopic bone 
formation at the medial collateral ligament (B). When cross-sectional surface areas were measured, a 
cholesterol-rich diet or LDL receptor deficiency showed increased total enthesophyte size in ligaments 
(C). ns = not significant compared to other groups; ‡P<0.05 compared to WT mice with normal diet.  
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FIG 5. Increased serum cholesterol levels enhance osteophyte formation at the margins of the tibial 
plateau and increase active TGF-β presence 
Osteophyte size was digitally measured at the margins of the tibial plateau (A). B shows representative 
photos (stained with safranin O - fast green) of osteophytes at the lateral side of the tibial plateau. The 
presence of active TGF-β was found to be increased in ldlr
-/-
 mice on a cholesterol-rich diet compared 
to WT mice on a cholesterol-rich diet by testing synovial wash-outs on a CAGA-Luc assay (C). *P<0.05; 
**P<0.01; ***P<0.001. n = 10 mice per group. 
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For that reason, bone marrow derived macrophages were cultured with oxLDL for 24 hours. 
Staining with oil red O indeed showed a high uptake of oxLDL by macrophages, which did 
not alter cell viability (Figure 6A). Analysis of RNA expression did not show upregulation of 
important growth factors known to be involved in ectopic bone formation such as Tgf-b, 
Bmp2, -4 and -7, while Il12p40, a positive control for murine oxLDL-laden macrophages
36
, 
did show a significant down regulation with a ΔΔCt of 2.0 ± 0.13 (Figure 6B). Next, we 
studied the presence of active TGF-β and BMP using specific bioassays. When supernatant 
of macrophages that were stimulated with oxLDL for 48 hours was functionally tested for 
TGF-β activity using the CAGA-Luc assay, we found a significant 2.9 fold increase in signal 
(P<0.05), while oxLDL alone did not increase TGF-β activity (Figure 6C). The BRE-Luc assay, 
which measures active BMP, did also show an increase in signal by supernatant of oxLDL-
laden macrophages, albeit to a lesser extent (fold increase 1.8; P<0.05; Figure 6D).  
Discussion 
In the present study, we show that enhanced serum LDL cholesterol levels increase ectopic 
bone formation in mice with collagenase-induced OA. By using both a cholesterol-rich diet 
and LDLR-deficiency, we demonstrated that an enhanced LDL cholesterol level in particular, 
rather than LDLR-deficiency or a specific food element, is responsible for the enhancement 
of ectopic bone formation.  
From previous studies we know that synovial lining cells are important for OA pathology. 
Selective elimination of synovial macrophages from the intimal lining of the knee joint prior 
to induction of collagenase-induced OA ameliorated the development of both cartilage 
damage and ectopic bone formation. In mice that lack the LDLR, a cholesterol-rich diet led 
to a strong increase in APOB staining within the lining layer. Every LDL particle contains a 
single APOB molecule that can be used as a marker for LDL and oxLDL uptake
37
. The 
accumulation of APOB in synovial lining cells of LDLR-deficient mice suggests that lining 
cells in an OA joint take up oxLDL in a cholesterol-rich environment. 
Macrophages can phagocytize LDL via the LDLR which is suppressed when LDL serum levels 
rise, leading to regulation of LDL uptake into the cell
38
. Under inflammatory conditions, LDL 
is oxidized and phagocytized by scavenger type A and B receptors lacking this negative 
feedback loop
39
. A macrophage is a very plastic cell type which can differentiate into 
activated M1 or suppressive M2 subtypes. Recently we found in in vitro studies that M2 
macrophages express higher levels of SR-A and CD36 receptors compared to M1 
macrophages and that enhanced uptake of oxLDL by M2 macrophages changed the 
suppressive character of this cell type into an M1-like macrophage releasing enhanced 
levels of IL-1 and IL-6
18
. 
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FIG 6. LDL- and oxLDL-laden macrophages enhance anabolic processes by activating TGF-β and to a 
lesser extent BMP, rather than increase production of TGF-β or BMP 
Bone marrow derived cells were differentiated into macrophages, after which they were stimulated 
with 50 mg/mL oxLDL or an equal volume of PBS. Staining the cells with oil red O showed uptake of 
oxLDL (A). RNA expression did not show significant upregulation of TGF-β, BMP2, BMP4 or BMP7 (B); 
however, a functional TGF-β reporter gene luciferase (CAGA-Luc) assay did show increased presence of 
active TGF-β (C). Furthermore, the BMP responsive luciferase (BRE-Luc) assay also showed increased 
activity in supernatant of oxLDL stimulated macrophages, albeit to a lesser extent (D). 
UD = undetectable; *P<0.05 versus unstimulated control; **P<0.01; ns = no significant regulation. 
 
Although uptake of oxLDL in the lining layer of the Ldlr
-/-
 mice receiving a cholesterol-rich 
diet was strongly enhanced, no elevation of S100A8 staining was observed. S100A8 is a 
member of the alarmin family which is particularly produced by activated macrophages but 
not by non-activated macrophages and has been described as a marker for macrophage 
activation
34
. The lack of S100A8 staining in Ldlr
-/-
 mice suggests that uptake of large 
amounts of oxLDL by lining macrophages does not enhance the production of pro-
inflammatory molecules and chemokines and, therefore, does not alter synovial thickening 
and cartilage destruction. In contrast, high cholesterol levels in WT mice induced only 
minor uptake of oxLDL by lining macrophages, but strongly enhanced S100A8 levels. This 
accumulation of S100A8 within the lining layer might explain the trend of increased 
cartilage destruction observed in WT mice on a cholesterol-rich diet. S100A8 production by 
A B 
C 
D 
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synovial macrophages may be driven by moderate uptake of oxLDL or LDL, while excessive 
uptake of oxLDL may inhibit production of pro-inflammatory factors by synovial 
macrophages. Another explanation of the slight increase in cartilage damage observed in 
WT mice on a cholesterol-rich diet (Figure 3) is that it might also be due to the increased 
body weight (Figure 1A). Nevertheless, by using a cholesterol-rich diet rather than a high-
fat diet, we minimized weight gain, preventing amelioration of the OA process via increased 
loading
40
. Lack of cartilage damage in cholesterol-rich conditions may also be explained by 
the increased presence of active TGF-β which protects the cartilage from proteoglycan 
depletion and matrix breakdown, as described in an earlier study by Van Beuningen et al.
41
. 
From our own experience, we know that the experimental model which is used here is less 
severe in female mice compared to males. Although all mice in this experiment developed 
cartilage lesions, the OA scores were relatively low. It would be interesting to repeat our 
experiment in a more severe model, investigating whether increased cholesterol-associated 
cartilage damage is detected.  
Apart from cartilage destruction, new formation of cartilage and bone is also observed in 
ligaments and locations along the bone surface during collagenase-induced OA. Focusing 
on ligaments (enthesophyte formation), we noticed that an increase in LDL levels by a 
cholesterol-rich diet markedly enhanced new cartilage and bone formation. OxLDL might 
directly induce proliferation and differentiation of stem cells present within the ligaments, 
or indirectly by enhancing growth factor production in synovium. Several studies have 
shown that oxLDL has a toxic effect on proliferation and differentiation of stem cells, and, 
in line with that, our own findings show that oxLDL (50 μg/mL) is highly toxic for stem cells 
(data not shown), whereas similar concentrations do not affect macrophage viability 
(Figure 6A)
42-46
. For that reason, we assume that enthesophyte formation may be more 
related to the effects of oxLDL on synovial lining activity. In previous studies in our lab it 
was found that intra-articular injection of the growth factors TGF-β and BMP2 resulted in 
formation of osteophytes
24,25
. Moreover, in the absence of synovial macrophages, injection 
of TGF-β was less able to induce new formation of cartilage and bone, suggesting that 
macrophages are crucial in mediating TGF-β effects
26
. Furthermore, we found that spheroid 
formation in a mesenchymal cell line was increased when these cells were co-cultured with 
macrophages, whereas total TGF-β levels in supernatant did not increase
27
. This fits with 
the present study where we show that there is increased activation of TGF-β, rather than 
production after stimulation of macrophages with oxLDL. Using supernatants of oxLDL 
stimulated macrophages, strongly elevated levels of active TGF-β and, to a lesser extent, 
BMP were measured. Also in vivo, Ldlr
-/-
 mice show an increased presence of TGF-β 
compared to WT mice, suggesting that this in vitro observation could very well reflect the in 
vivo mechanism. TGF-β was measured using a CAGA-Luc assay in which the CAGA promoter 
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is coupled to a luciferase gene which becomes activated by active TGF-β via TGF-β receptor 
1. TGF-β is released in an inactive form and can be activated by enzymes such as MMP2 
and MMP9
47
. These enzymes may be released either by activated synovial macrophages or 
by synovial fibroblasts in response to pro-inflammatory factors released by the 
macrophage. Recently, Ishikawa et al. demonstrated that apart from macrophages in 
rheumatoid arthritis fibroblast-like synoviocytes can also accumulate oxLDL via LOX-1, 
resulting in massive MMP production
48
. Studies are now in progress to define the factors 
involved in TGF-β activation. In addition to TGF-β activation, increased BMP activation was 
found after stimulation of macrophages with oxLDL. Enhanced BMP presence can also 
contribute to the observed bone formation, since previous studies showed that TGF-β is 
important for initiating osteophyte formation, whereas BMP are mainly involved at later 
stages in the process of endochondral ossification
49
. Also osteoarthritic chondrocytes have 
been shown to express LOX-1 and could, therefore, be affected by oxLDL directly
50
. 
Although our data support that (ox)LDL affects chondrocytes indirectly via synovial 
activation, it would be interesting to investigate how hypercholesterolemia could influence 
the chondrocytes directly and how this affects OA development.  
We did not find osteophyte or enthesophyte formation in naïve knee joints of mice with an 
LDLR-deficiency receiving a cholesterol-rich diet (data not shown). This would suggest that 
systemically enhanced LDL levels alone are not sufficient to induce joint pathology. Only 
when there are pro-inflammatory or damage associated stimuli present (that is, during OA 
or instability), may enhanced LDL levels result in increased osteophyte/enthesophyte 
formation.  
This study shows for the first time that increased LDL cholesterol levels in an OA milieu are 
able to enhance ectopic bone formation. Our experimental data points towards a potential 
mechanism in which uptake of oxLDL by synovial lining macrophages results in activation of 
TGF-β and to a lesser extent BMP. Further research is needed in order to elucidate what 
factors in particular are responsible for the enhanced levels of active TGF-β and BMP, since 
direct production does not seem to increase according to mRNA expression levels. 
Nevertheless, this mechanism provides a firm step forward to unraveling possible factors 
affecting etiopathology of OA and osteophyte formation in particular. 
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Abstract 
Introduction 
Alarmins S100A8 and S100A9 are major products of activated macrophages regulating 
cartilage damage and synovial activation during murine and human osteoarthritis (OA). In 
the current study, we investigated whether S100A8 and S100A9 are involved in osteophyte 
formation during experimental OA and whether S100A8/A9 predicts osteophyte 
progression in early human OA.  
Methods 
OA was elicited in S100a9
-/-
 mice in two experimental models that differ in degree of 
synovial activation. Osteophyte size, S100A8, S100A9 and VDIPEN neoepitope was 
measured histologically. Chondrogenesis was induced in murine mesenchymal stem cells in 
the presence of S100A8. Levels of S100A8/A9 were determined in plasma of early 
symptomatic OA participants of the Cohort Hip and Cohort Knee (CHECK) cohort study and 
osteophytes measured after 2 and 5 years.  
Results 
Osteophyte size was drastically reduced in S100a9
-/-
 mice in ligaments and at medial femur 
and tibia on days 21 and 42 of collagenase-induced OA, in which synovial activation is high. 
In contrast, osteophyte size was not reduced in S100a9
-/-
 mice during destabilised medial 
meniscus OA, in which synovial activation is scant. S100A8 increased expression and 
activation of matrix metalloproteinases during micromass chondrogenesis, thereby possibly 
increasing cartilage matrix remodelling allowing for larger osteophytes. Interestingly, early 
symptomatic OA participants of the CHECK study with osteophyte progression after 2 and 5 
years had elevated S100A8/A9 plasma levels at baseline, while C-reactive protein, 
erythrocyte sedimentation rate and cartilage oligomeric matrix protein were not elevated 
at baseline.  
Conclusions 
S100A8/A9 aggravate osteophyte formation in experimental OA with high synovial 
activation and may be used to predict osteophyte progression in early symptomatic human 
OA. 
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Introduction 
Recently, the view on osteoarthritis (OA) is shifting from a disease of only the cartilage to a 
whole joint disease. Synovial activation and pro-inflammatory mediators from the synovium 
play an important role in the pathogenesis of OA.
1-4
 An arthroscopic study suggests that 
synovial activation occurs in 50% of patients with OA
5
 and synovitis is associated and can 
predict cartilage pathology
6,7
. We previously showed that synovial macrophages are 
essential in regulating synovial inflammation and subsequent cartilage erosion during 
collagenase-induced OA (CiOA)
8
. Important products from activated macrophages are the 
alarmins S100A8 and S100A9. These damage-associated molecular patterns bind calcium 
and can also be released in huge amounts by neutrophils and monocytes
9,10
. S100A8/A9 is 
highly present in synovial fluid of both patients with rheumatoid arthritis (RA) and OA
11
; 
and in RA both serum and synovial fluid levels of S100A8/A9 correlate with radiological 
damage and disease activity
12,13
. We recently showed that S100A8 and S100A9 induce a 
catabolic phenotype in human OA chondrocytes by upregulating pro-inflammatory 
cytokines and matrix metalloproteinases (MMP)-1, MMP -3, MMP -9 and MMP -13 via TLR-
4
14
. Furthermore, we demonstrated that S100a9
-/-
 mice showed reduced cartilage damage 
and synovial activation during CiOA, but not in the surgically induced destabilised medial 
meniscus (DMM) OA
15
. CiOA has considerably higher synovial activation compared with 
DMM, indicating the importance of S100A8/A9 in inflammatory OA.  
Osteophytes, important hallmarks of OA, are bony outgrowths lined by cartilage that limit 
joint movement and cause pain. While classic osteophytes originate from the periosteum, 
similar structures can also develop in ligaments and tendons, further also called 
osteophytes. Osteophytosis is initiated by mesenchymal stem cells (MSCs) that undergo 
condensation, chondrogenic differentiation and proliferation. Finally, the chondrocytes go 
into hypertrophy and blood vessels are formed that give access to osteoblasts and 
osteoclasts that transforms the structure into bone in a process highly resembling 
endochondral ossification
16
. Earlier, our lab has shown that overexpression of both 
transforming growth factor β-1 (TGF-β1) and bone morphogenetic protein-2 (BMP2) 
induces osteophyte formation in the mouse knee joint, although with different 
dynamics
17,18
. Consequently, we have shown that osteophyte formation is highly 
dependent on synovial macrophages, potent producers of TGF-β-superfamily members
19
.  
In the current study, we aimed to unravel the role of S100A8/A9 in osteophyte formation in 
experimental OA models, focusing on the involvement of the synovium. Moreover, we 
investigated whether S100A8/A9 plasma levels predict osteophyte progression in 
participants of the Dutch Cohort Hip and Cohort Knee (CHECK) cohort of early symptomatic 
OA.  
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Materials and methods 
Animals and experimental OA models 
Experimental OA was elicited in 12-week-old to 14-week-old male C57BL/6J (Janvier) and 
S100a9
-/-
 mice backcrossed to the C57BL/6 background for 12 generations. Mice were 
housed in groups of 10 animals in filter-top cages, and water and food were provided ad 
libitum. The study was approved by the medical ethics committees of all participating 
centers, and all participants gave their written informed consent before entering the study. 
CiOA was performed by two times intra-articular injection of 1U of bacterial collagenase 
(Sigma–Aldrich), causing disruption of the ligaments and local instability of the knee joint
20
. 
DMM OA was induced by transection of the medial anterior meniscotibial ligament
21
. All 
animal experiments were approved by the local ethics committee of the Radboud 
University Medical Center.  
Histology 
Total knee joints or micromasses were fixed in formalin and cut in 7 or 5 µm sections, 
respectively. Staining was done with Safranin-O (SafO) (0.1% in water), counterstaining with 
Fast Green (0.1% in water). Osteophyte size was assessed in SafO sections using the Leica 
Application Suite image analysis software. Knee joint sections were also immunostained 
with antirabbit S100A8, S100A9 (own facilities) or VDIPEN (neoepitope of aggrecan with 
amino acids valine (V), aspartic acid (D), isoleucine (I), proline (P), glutamic acid (E) and 
asparagine (N)), with rabbit immunoglobulin G (IgG) as isotype. Biotinylated horseradish 
peroxidase–conjugated goat antirabbit IgG (Dako) was used as secondary antibody, 
followed by avidin–streptavidin–peroxidase (Elite kit; Vector) and diaminobenzidine to 
develop peroxidase staining, enhanced with nickel for the VDIPEN staining. Counterstaining 
was done with Mayer's haematoxylin (Merck) for S100A8 and S100A9 and with Orange G 
(2%) for VDIPEN.  
Micromass chondrogenesis 
Chondrogenesis was studied by bringing the MSC cell line C3H10T1/2 in micromass pellets. 
In total, 250 000 cells were allowed to adhere in round-bottom 96-well plates for 3 h after 
which they spontaneously form microspheres of cells. Micromasses were stimulated with 
chondrogenic medium (Dulbecco's Modified Eagle Medium with 50 µg/mL vitamin C, 6.25 
µg/mL transferrin, 6.25 ng/mL sodium selenite, 5.35 µg/mL linoleic acid, 10
−7
 M 
dexamethasone, 6.25 µg/mL insulin, 1.0 mg/mL sodium pyruvate, 0.4 mg/mL prolin, 2% 
BSA and 48 µg/mL gentamicin) two times a week for 3 weeks, supplemented with 5 ng/mL 
TGF-β1, 50 ng/mL BMP2 and 5 µg/mL recombinant murine S100A8.  
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Determination of mRNA expression with real time-qPCR 
RNA was isolated from micromass cultures using TRI-reagent (Sigma-Aldrich), as described 
previously
22
. RNA from murine synovial biopsies was isolated using the RNeasy-kit (Qiagen), 
after first disrupting synovial tissue with the MagNA Lyser (Roche). RNA was reverse 
transcribed to cDNA and real time-qPCR was performed with specific primers and the SYBR 
Green Master mix in the StepOnePlus real-time PCR system (Applied Biosystems) as 
described before
22
. Expression levels are expressed as minus delta Ct (-dCt) values, 
normalised to the reference gene mGapdh. Primer sequences for target genes for RT-qPCR 
spanned exon-exon transitions and were as follows: mTgfbeta1; FW: 5’-
GCAGTGGCTGAACCAAGGA-3’, RV: 5’-AAGAGCAGTGAGCGCTGAATC-3’. mBmp2; FW: 5’-
CGCAGCTTCCATCACGAA-3’, RV: 5’-GCCGGGCCGTTTTCC-3’. mBmp6; FW: 5’-
GATGGCAGGACTGGATCATTG-3’, RV: 5’-AGGAACACTCTCCATCACAGTAGTTG-3’. mMmp2; 
FW: 5’-CATGCGGAAGCCAAGATGT-3’, RV: 5’-AGGTGTGTAACCAATGATCCTGTATGT-3’. 
mMmp3; FW: 5’-TGAAGCCACCAACATCAGGA-3’, RV: 5’-TGGAGCTGATGCATAAGCCC-3’. 
mMmp9; FW: 5’-GGAACTCACACGACATCTTCCA-3’, RV: 5’-GAAACTCACACGCCAGAAGAATTT-
3’. mMmp13; FW: 5’-AGACCTTGTGTTTGCAGAGCACTAC-3’, RV: 5’-
CTTCAGGATTCCCGCAAGAG-3’. 
Measurements in early symptomatic OA cohort (CHECK) 
Samples were obtained from CHECK. On entry into the CHECK study (=baseline), all 
participants had pain or stiffness of the knee or hip, and all of them were aged between 45 
and 65 years. They had not yet consulted their physician for these symptoms, or the first 
consultation occurred within 6 months before cohort entry. Participants with any other 
pathological condition that could explain the symptoms were excluded. Right or left knee 
pain was assessed at baseline and S100A8/A9 was measured in plasma of 58 participants of 
the CHECK cohort. Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and 
serum cartilage oligomeric matrix protein (COMP) was measured in the same participants, 
as described before
23
. Osteophytes of the tibiofemoral joints were made at baseline and 
after 2 and 5 years by a weight-bearing posteroanterior view, semiflexed (7°–10°). Femoral 
medial and lateral osteophytes, and tibial medial and lateral osteophytes were scored on a 
0–3 scale according to Altman and Gold
24
. Participants were categorised into osteophyte 
progressors and non-progressors: progressors (n=34) were participants that had pain in left 
or right knee (or both) at baseline and consequently developed osteophytes or increased 
their osteophyte size after either 2 or 5 years in that particular knee on any of the four 
measured locations. Non-progressors (n=24) did have pain in the knee, but did not develop 
or increase osteophytes in that particular knee. All except two non-progressors also did not 
have osteophyte progression in the other knee. CHECK is a Dutch prospective cohort study 
of a total of 1,002 individuals with early symptomatic OA of the knee or hip
25
. The CHECK 
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cohort was initiated by the Dutch Arthritis Association and performed at Erasmus Medical 
Centre Rotterdam, Kennemer Gasthuis Haarlem, Leiden University Medical Centre, 
Maastricht University Medical Centre, Martini Hospital Groningen/Allied Health Care Centre 
for Rheumatology and Rehabilitation Groningen, Medical Spectrum Twente Enschede, 
Ziekenhuisgroep Twente Almelo, Reade/Jan van Breemen Research Institute and VU 
Medical Center Amsterdam, St. Maartenskliniek Nijmegen, University Medical Centre 
Utrecht, and Wilhelmina Hospital Assen. 
Measurement of TGFβ activity 
TGFβ activity was determined by adding 1:5 dilution of synovial washouts of CIOA mice
26
 
overnight to 3T3 fibroblasts transduced with adenoviral CAGA-luciferase (CAGA-luc) with a 
multiplicity of infection (MOI) of 10 (10 plaque-forming units) per cell, after which 
luminescence was measured. The plasmid was kindly provided by Dr. Ten Dijke 
(Department of Molecular Cell Biology, Leiden University Medical Center, The Netherlands). 
The CAGA-boxes in the vector are transcribed by Smad3/4 through active TGFβ, resulting in 
luciferase activity
27
. 
Measurement of S100A8/A9 protein 
S100A8/A9 concentrations were determined in serum of mice with experimental OA or 
plasma of human CHECK samples and in synovial washouts of murine knee joints by a 
sandwich enzyme-linked immunosorbent assay (ELISA) specifically for either murine or 
human S100A8/A9 as described previously
28
. 
Statistical analysis 
Statistical differences were calculated using an unpaired t-test unless stated otherwise with 
Graph Pad Prism 5 (GraphPad Software). Differences were called significant with P-value < 
0.05 (*), < 0.01 (**) or <0.0005(***). 
Results 
Development of osteophytes during CiOA coincides with high synovial and serum S100A8/A9 
protein levels 
Recently, we have shown that S100A8/A9 drives cartilage destruction in CiOA
15
, a model 
with high synovial activation. Within this model we explored whether S100A8/A9 is 
associated with osteophyte formation. On days 7, 21 and 42 after induction of CiOA, we 
stained whole knee sections with SafO and immunostained for S100A8 and S100A9.  
After 1 week of CiOA, osteophytes started to develop, as evidenced by chondrogenesis 
particularly at the medial and lateral margins of the femur. However, no chondrogenesis 
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was seen in the ligaments yet. Interestingly, very strong S100A9 expression at this time 
point was found in the synovial lining layer (figure 1A). On day 21 of CiOA, bone deposition 
was observed in the osteophytes as they increased in size. 
Furthermore, osteophytes started developing in the medial collateral ligament. S100A9 
expression on day 21 was still high in the synovial lining layer (figure 1B). On day 42, fully 
developed and large osteophytes were observed particularly at the medial side, but also at 
the lateral side. Although decreased compared with days 7 and 21, S100A9 was still 
expressed in the synovial lining layer on day 42 (figure 1C). A naive knee joint did not show 
any osteophytes and isotype staining for S100A9 was negative (figure 1E). Immunostaining 
of S100A8 was comparable with S100A9 (not shown). S100A8/A9 protein levels in serum 
 
FIG 1. Time course of osteophyte development during collagenase-induced osteoarthritis and S100A8/A9 
protein expression in synovium and serum 
CiOA was elicited in C57/Bl6 mice and histology of total knees was taken on 7 (A), 21 (B) and 42 days 
(C) after induction. At the same days after CiOA induction, S100A8/A9 serum levels were measured 
with a specific ELISA (D). Paraffin-embedded sections were stained for proteoglycans with Safranin-O 
(A–C upper panels) and S100A8 (not shown) and S100A9 were immunostained in adjoining sections 
(A–C lower panels). (A) On day 7, chondrogenesis in developing osteophytes was almost exclusively 
seen at the medial and lateral margins of the femur, while S100A9 expression was highly expressed in 
the synovial lining. (B) On day 21, chondrogenesis was observed in medial collateral and cruciate 
ligaments and at the margins of tibia and femur while S100A9 staining was observed in the synovial 
lining layer with similar intensity as on day 7. (C) On day 42, bone development in about 50% of 
osteophytes in both ligaments and femur and tibia margins was observed, as osteophytes grew to 
larger size. Interestingly, S100A9 staining was still present in the synovial lining layer, although less 
intense. (E) Safranin-O staining of naive, non-OA mouse knee joint, showing no 
chondrogenesis/osteophyte formation. Specific RbIgG isotype staining of S100A9 in the right panel. 
Magnifications are either 50× or 200× for safranin-O and 400× for S100A9 stained sections. (A–C) 
n=10 mice/group, results are representative for two independent experiments. In (D), average serum 
S100A8/A9 levels are shown of four independent experiments. 
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were high on both days 7 and 21 (figure 1D) and returned to control (non-OA) levels on day 
42. Together, these results show that S100A8 and S100A9 are present during CiOA in the 
synovium during the first phases of osteophytosis. 
Osteophyte size is drastically reduced in S100a9
-/-
 mice with CiOA 
Next, we investigated whether S100A8/S100A9 could affect osteophyte development by 
inducing CiOA in knee joints of mice deficient for S100A9. The peripheral myeloid cells of 
these mice also lack S100A8 protein, while S100A8 protein was also hardly detectable in 
the joint (supplementary figure S1), which make them a functional double knockout
29
. On 
day 7, both wildtype (WT) and S100a9
-/-
 mice showed small areas with chondrogenesis at 
the medial femur (figure 2A). Interestingly, on day 21 osteophytes were greatly reduced in 
S100a9
-/-
 mice on the margin of the medial femur and tibia (56% and 67% reduction 
compared with WT, respectively) (figure 2B) and even slightly more reduced on day 42 
(65% and 68% reduction) (figure 2C, D). Osteophytes at the cruciate ligament were also 
significantly smaller at day 21 (58% reduction) and a non-significant reduction was 
observed in the medial collateral ligament (figure 2B). Finally, we observed a dramatic 
reduction in osteophyte size at the medial collateral ligament on day 42 in S100a9
-/-
 mice 
(92% compared with WT) (figure 2C, D).  
Osteophyte size is not reduced in S100a9
-/-
 during experimental OA with low synovial 
activation 
To investigate whether S100A8/A9 released by the activated synovium is important in the 
reduction of osteophyte size, we induced experimental OA in S100a9
-/-
 mice by DMM. In 
contrast to CiOA, synovial activation is very low during DMM
15
. No significant changes in 
osteophyte size were found on day 56 of DMM, neither at the medial femur nor tibia, the 
locations to which osteophyte formation is mainly restricted to during DMM (figure 3A, B). 
The results in the CiOA and DMM model suggest that S100A8/A9 from the synovium 
stimulates osteophyte development. 
S100A8/A9 does not regulate growth factor levels and activation during CiOA 
Earlier, our lab has shown that growth factors such as BMP2 and TGF-β play a major role in 
the development of osteophytes during CiOA
18,30
. To investigate whether the reduced 
osteophyte size in S100a9
-/-
 mice during CiOA was due to a reduction in growth factors, we 
measured synovial mRNA expression on 7, 21 and 42 days after induction of OA. No 
differences in mRNA expression for TGF-β-family members TGF-β1, BMP2 and BMP6 were 
found between S100a9
-/-
 and WT (figure 4A). Nor was there an effect on the activation of 
TGF-β, as measured with CAGA-Luc in synovial washouts (figure 4B). 
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FIG 2. Osteophyte size is drastically reduced in S100A9
-/-
 mice at days 21 and 42 of collagenase-induced 
osteoarthritis. 
CiOA was elicited in S100A9
-/-
 mice and osteophyte size was measured with image analysis software at 
7 (A), 21 (B) and 42 (C and D) days at lateral femur, medial femur and tibia and at medial and lateral 
collateral ligaments on safranin-O (Saf-O)-stained histological sections. (A) On day 7, osteophyte size 
was still small and only slightly reduced at the lateral femur, not on other locations. No 
chondrogenesis was yet observed inside the lateral and medial collateral ligaments. (B) On day 21, 
osteophytes were larger and significantly reduced in the S100A9
-/-
 mice at medial femur and tibia, as 
well as inside the cruciate ligament. A trend towards smaller osteophyte size was observed inside the 
medial collateral ligament. (C) On day 42, osteophyte size was drastically reduced at again medial 
femur and tibia, as well as at the medial collateral ligament. (D) Photomicrographs (magnification 
50×) of representative Saf-O-stained sections of osteophytes on day 42 of both wild type and S100A9
-/-
 
mice.  
S100A8/A9 increase remodelling of the cartilage matrix during chondrogenesis by 
upregulating and activating MMPs 
Chondrogenesis of MSCs is an early key feature of osteophyte development
16
, and since 
S100A8/A9 expression was highest at early phases of CiOA (figure 1), we studied the effect 
of S100A8 on chondrogenesis in more detail. Chondrogenesis was present in S100A8-
supplemented micromasses, as shown by Saf-O staining of proteoglycans. However, the 
integrity of the S100A8-supplemented micromasses was completely lost as they seemed to 
collapse and protrusions appeared (figure 5A). Measuring MMP mRNA levels in these 
micromasses, we found that particularly MMP-3 was greatly upregulated by adding S100A8 
(96-fold), while chondrogenic markers collagen type II and aggrecan were not changed 
(figure 5B). Moreover, we also found higher MMP activity as measured by an increase in 
the neoepitope VDIPEN
31
, which is specific for proteoglycans cleaved by MMPs (figure 5C). 
These results indicate that S100A8 can activate MMPs during chondrogenesis. Finally, we 
analysed MMP activation during chondrogenesis in vivo, at day 7 of CiOA. High expression 
53 
 
of VDIPEN coincided with areas of high proteoglycan content in areas of emerging 
osteophytes (figure 5D), suggesting that indeed MMP activation and activity is important in 
chondrogenesis during osteophyte formation. 
 
FIG 3. Osteophyte size is not reduced in S100A9
-/-
 mice with surgically induced destabilized medial 
meniscus osteoarthritis 
DMM OA was induced in S100A9
-/-
 mice and osteophyte size was measured on day 56. Osteophytes in 
the DMM model, which lacks synovial activation, develop almost exclusively at the margins of the 
medial tibia and femur. (A) On day 56, osteophyte size at medial tibia and femur was unchanged in 
S100A9
-/-
 compared with wildtype (WT). (B) Photomicrographs (magnification 50×) of representative 
safranin-O (Saf-O)-stained sections of osteophytes on day 56 of both WT and S100A9
-/-
 mice.  
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FIG 4. S100A8/A9 do not alter growth factor and MMP expression nor TGF-β activation in the synovium 
during CiOA 
CiOA was elicited in S100A9
-/-
 mice and synovial mRNA samples and synovial washouts were collected 
after 7, 21 and 42 days. (A) mRNA levels of growth factors TGF-β1, BMP2 and -6 and of MMP-3 and -
13 were measured with real time-qPCR and no differences were found between S100A9
-/-
 and WT 
mice on all time points, days 7, 21 and 42. (B) TGF-β activation was measured in synovial washouts. 
No differences between S100A9
-/-
 and WT mice on synovial TGF-β activation as measured by 
luminescence using the TGF-β-responsive CAGA-Luc assay. 
S100A8/A9 predicts osteophyte progression in early human OA 
Our current findings in the mouse prompted us to investigate whether S100A8/A9 levels 
could predict the progression of osteophytes in humans. For this we measured S100A8/A9 
levels in plasma of participants in a sample of the CHECK cohort (n=58) of early 
symptomatic OA at baseline and scored osteophytes by radiograph analysis at baseline and 
after 2 and 5 years
24
. Progressors were defined as participants that had increased 
osteophyte score after 2 or 5 years after having had pain in that knee at baseline, while 
non-progressors did not increase their knee osteophyte score after 2 or 5 years despite 
having knee pain at baseline. Progressors and non-progressors were matched for sex, age 
and body mass index. Demographic data show no significant differences between 
progressors and non-progressors (supplementary table S1). Interestingly, progressors 
already had elevated osteophyte scores at baseline (supplementary table S1). Remarkably, 
we found significantly elevated S100A8/A9 levels in progressors (n=34) of osteophyte 
formation compared with non-progressors (n=24) (451 vs 254 ng/mL) (figure 6A). 
Furthermore, participants with S100A8/A9 plasma concentrations higher than 200 ng/mL 
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had increased odds of developing osteophytes (OR 4.0; p=0.01, χ
2
), indicating an increased 
risk of osteophyte progression when S100A8/A9 levels are high. Moreover, we measured 
CRP and ESR in these participants, common parameters for inflammation in arthritic 
disease, and found that this was not different between progressors and non-progressors 
(figure 6B, C). Also, COMP, a widely used marker for cartilage damage, was not changed 
(figure 6D). 
 
 
FIG 5. S100A8 increases cartilage remodelling during micromass chondrogenesis by upregulating and 
activating matrix metalloproteinases 
Chondrogenesis was induced in micromasses of murine mesenchymal stem cells (C3H10T1/2), in the 
presence of 5 ng/mL TGF-β1 and 50 ng/mL BMP2, with or without (=control) 5 µg/mL recombinant 
S100A8. (A) No chondrogenesis was observed after 21 days in conditions without TGF-β1/BMP2 (A, 
left panels). Proper chondrogenesis was seen in the TGF-β1/BMP2 stimulated micromasses as 
evidenced by safranin-O (Saf-O) proteoglycan staining (A, bottom middle panels). S100A8 
supplemented micromasses did show chondrogenesis, but showed protrusions or total collapse of 
micromasses (A, top middle panels). Detailed pictures (200× magnification) of chondrogenic area 
with/without S100A8 in top and bottom-right panels. (B) MMP-3, collagen type II and aggrecan mRNA 
levels were upregulated in micromasses stimulated with S100A8, with or without TGF-β1/BMP2. (C) 
MMP activation was upregulated in S100A8 stimulated micromasses, as evidenced by heightened 
immunostaining of the MMP-specific cartilage matrix breakdown neoepitope VDIPEN. (D) On day 7 of 
collagenase-induced -osteoarthritis (CiOA), VDIPEN expression as measure of MMP activation (left 
panel) coincides with proteoglycan content (safranin-O, right panel) in developing osteophytes. 
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FIG 6. High plasma levels of S100A8/A9 predict knee osteophyte progression at 2 or 5 years in an early 
symptomatic osteoarthritis cohort 
Plasma levels of S100A8/A9, serum levels of C-reactive protein and cartilage oligomeric matrix protein 
and erythrocyte sedimentation rate were measured at baseline in 58 participants of a Dutch early 
symptomatic OA cohort, Cohort Hip and Cohort Knee. Osteophyte progression was measured by 
radiograph analysis. (A) S100A8/A9 plasma levels are significantly upregulated at baseline in 
participants that developed knee osteophytes after 2 or 5 years after having had knee pain at baseline 
(=progressors, n=34) compared with participants that did not develop any knee osteophytes after 2 or 
5 years, despite having knee pain at baseline (=non-progressors, n=24). (B and C) In contrast, standard 
markers for inflammation, ESR (B) and CRP (C) are not elevated at baseline in progressors compared 
with non-progressors. (D) Finally, COMP, a standard clinical marker for cartilage damage, was also not 
elevated in progressors at baseline. 
Discussion 
In the current study, we show that alarmins S100A8 and S100A9 aggravate osteophyte 
formation during experimental OA with high synovial activation. Moreover, S100A8/A9 can 
upregulate and activate MMPs, thereby possibly enhancing remodelling during 
osteophytosis and allowing for larger osteophytes. Finally, we confirmed the relevance of 
S100A8/A9 during osteophyte formation in humans by showing that elevated S100A8/A9 
plasma levels in people with early symptomatic OA at baseline have a predictive value for 
development of osteophytes after 2 or 5 years.  
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Using S100a9
-/-
 mice first in CiOA, we have shown that S100A8 and S100A9 are important 
for the development of large osteophytes at both the bone margins and in ligaments. Since 
we have shown earlier that cartilage damage is reduced in S100a9
-/-
 mice during CiOA
15
, 
S100A8/A9 could indirectly contribute to osteophyte size through cartilage damage and 
cartilage breakdown products. However, we clearly show that osteophyte formation 
already starts early during CiOA (day 7, figure 1A), while the onset of cartilage damage 
occurs around day 14. Moreover, synovial activation occurs early during CiOA and is 
reduced in S100a9
-/-
 mice
15
. As such, we cannot completely rule out that S100A8/A9 could 
have its effect on osteophyte formation indirectly via synovial activation.  
Osteophyte size was not reduced in S100a9
-/-
 mice during DMM OA. Considering the near 
absence of synovitis during DMM, this again points to an important role for synovial 
activation in osteophyte formation. Although we have shown low S100A8/A9 levels in the 
synovium during DMM
15
, a role for S100A8/A9 inside the chondrocyte on osteophyte 
formation cannot be fully excluded. Zreiqat et al.
32
 showed expression of S100A8 and 
S100A9 in chondrocytes during DMM. However, we were unable to detect S100A8/A9 in 
supernatants of human OA and murine chondrocytes nor show S100A8 or S100A9 on 
western blot in chondrocyte cell lysates (unpublished results), indicating a marginal role for 
these alarmins in chondrocytes.  
These results together suggest that synovial activation and consequently factors released 
by macrophages/infiltrated monocytes, such as S100A8 and S100A9, could stimulate 
osteophyte formation.  
Intra-articular injection and adenoviral overexpression of both TGF-β1 and BMP2 induces 
osteophyte formation in the mouse
17,18,33
. In the current study, we could not find changes 
on synovial mRNA expression of TGF-β1 and BMP2 nor levels of active TGF-β in S100a9
-/-
 
during CiOA. TGF-β levels, however, are already high during CiOA and S100A8/A9 could be 
working as an enhancer to increase osteophyte size through catabolic actions.  
Our lab has extensively shown that S100A8 and S100A9 are capable of upregulating and 
activating MMPs in chondrocytes
14,34
. From developmental knockout studies in mice, it is 
clear that MMPs are essential for proper endochondral ossification, a process similar to 
osteophyte formation
35,36
, and MMP-3 is strongly expressed within adult human 
osteophytic bone
37
. In line with this, we showed in the present study that S100A8 could 
upregulate MMP-3 mRNA and activate MMPs in differentiating chondrocytes derived from 
murine MSCs. Moreover, we showed that VDIPEN expression and thus MMP activation is 
elevated in vivo during CiOA in the same areas in which chondrogenesis occurs. This 
supports the view that S100A8 and S100A9 can increase osteophyte size through activation 
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of MMPs. By breaking down the cartilage matrix, MMPs could make it possible for 
chondrocytes to proliferate further and form larger osteophytes. These results together 
indicate that (MMP-mediated) catabolic rather than anabolic mechanisms are responsible 
for the proposed effects of S100A8/A9 on osteophyte formation.  
CHECK has as main goal to identify factors important for the (early) onset and development 
of OA. Studies using the CHECK cohort of early symptomatic OA participants already 
identified several biomarkers and diagnostic tools for early OA
38,39
. Especially early 
diagnosis could vastly improve OA therapeutics since it has proven almost impossible to 
reverse structural deformities in the later stages of the disease and clinicians often revert 
to total joint replacement. We found that plasma S100A8/A9 is significantly higher in 
CHECK participants that develop osteophytes, but remarkably this is not the case for CRP, 
ESR and COMP. Plasma S100A8/A9 higher than 200 ng/mL also indicate a four times higher 
risk of developing osteophytes at later stages. Recently, we also showed a thickened intima 
lining of the synovium of CHECK participants that correlated with S100A8/A9 expression on 
immunohistochemistry. Also, we showed that high serum S100A8/A9 levels correlate with 
the development of cartilage damage in symptomatic patients with OA
15
. This study further 
increases the value of measuring S100A8/A9 at an early stage of OA as possible predictor of 
both cartilage damage and osteophyte formation, although the number of participants 
(n=58) needs to increase to be able to assess proper prognostic value of S100A8/A9.  
Taken together the current study shows that S100A8 and S100A9, as important products of 
activated macrophages during synovial activation in OA, could increase osteophyte size 
during experimental OA with synovial inflammation. S100A8/A9 can upregulate and 
activate MMPs that aid in the remodelling of the cartilage matrix, allowing for osteophytes 
to increase in size. Finally, we showed that S100A8/A9 may prove an interesting biomarker 
to predict cartilage damage and osteophyte progression during human OA.  
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Table S1. Demographic data participants CHECK cohort 
Variable Progressors Non-progressors Significance 
Gender (male vs. female) 21% vs. 79% 21% vs. 79% - 
Age 57.4 (± 4.8) 56.1 (± 5.2) ns 
BMI 28.8 (± 4.9) 26.7 (± 3.3) ns 
Serum cholesterol (mmol/L) 56.8 (± 22.9) 53.2 (± 18.5) ns 
Total osteophyte BL 0.478 (± 0.39) 0.198 (± 0.30) P < 0.05 
Demographic parameters were not different between progressors (n=34) and non-progressors 
(n=24). BMI, Body Mass Index; BL, baseline. Total osteophyte score calculated by taking average 
osteophyte scores (0-3) of 4 locations per knee (medial and lateral tibia/femur) left and right. P-
values were determined using Mann-Whitney test. ns, non-significant. 
 
 
 
 
 
 
FIG S1. S100A8 protein is very sparsely expressed in the joint of S100A9 knockout mice 
Paraffin-embedded sections of S100A9 knockout (A) and WT mice (C57Bl/6J) on day 21 of 
collagenase-induced OA (B) were stained with specific anti-rabbit S100A8. A, S100A8 proteinwas 
sparsely expressed only in the bone marrow, not in other cells. B, S100A8 protein is abundantly 
expressed in synovial lining, bone marrow and growth-plate mostly. 
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Abstract 
Introduction 
A relation between osteoarthritis (OA) and increased cholesterol levels is apparent. In the 
present study we investigate OA pathology in apolipoprotein E-deficient (Apoe
−/−
) mice with 
and without a cholesterol-rich diet, a model for high systemic low density lipoprotein (LDL) 
cholesterol levels independent of weight. 
Methods 
Wild type (WT), Apoe
−/−
, S100a9
−/−
 and Apoe
−/−
S100a9
−/−
 mice (C57BL/6 background) 
received a standard or cholesterol-rich diet. Experimental OA was induced by intra-articular 
injection of collagenase and animals were sacrificed at day 10 and day 36. 
Results 
Although minimal differences in cartilage damage were found between the WT and Apoe
−/−
 
mice, increased synovial thickening was found in the latter. Thirty-six days after OA-
induction, Apoe
−/−
 mice on a standard diet showed increased ectopic bone formation, 
particularly at the medial collateral ligament, compared with OA in WT mice. Furthermore, 
a significant increase in synovial gene expression of both S100a8 and S100a9 and 
S100A8/S100A9 protein levels was found in Apoe
−/−
 mice, suggesting an activated 
inflammatory status of synovial cells. 
In both Apoe
−/−
 and WT mice, addition of a cholesterol-rich diet resulted in excessive bone 
formation in the medial collateral ligament at late-time-point OA. Interestingly, at the early 
time point, proteoglycan deposition was already significantly increased in Apoe
−/−
 mice 
compared with WT mice. Mice deficient for both ApoE and S100A9 also showed increased 
ectopic bone formation, but not synovial activation, suggesting a role for S100-proteins in 
cholesterol-mediated synovial activation. 
Conclusions 
Increased cholesterol levels strongly elevate synovial activation and ectopic bone formation 
in early-stage collagenase-induced OA. 
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Introduction 
Osteoarthritis (OA) is a chronic disease affecting the entire joint. The disease is mainly 
characterized by joint degeneration including destruction of articular cartilage and ectopic 
bone formation. Yet, a substantial population of patients develops synovial inflammation, 
suggesting involvement of the synovial lining layer in OA
1
. Earlier studies have shown that 
synovial lining macrophages are crucial in processes such as synovial inflammation
2,3
, and 
are involved in cartilage destruction
4
 and osteophyte formation
5
 during human and 
experimental OA. 
OA has been associated with increased low density lipoprotein (LDL) levels, however, the 
exact mechanism remains unclear
6-10
. Recently, we showed that increased LDL-cholesterol 
levels in LDL receptor deficient (Ldlr
−/−
) mice lead to increased ectopic bone formation 
during experimental OA
11
. During OA, growth factors from the transforming growth factor 
(TGF) superfamily, such as TGF-beta (β) and bone morphogenetic proteins (BMPs), are 
thought to be involved by inducing de novo formation of ectopic bone
12,13
. Earlier, we 
showed that multiple injections of TGF-β and BMP2 into the knee joint induce massive 
ectopic bone formation
14,15
 and we postulated that factors produced by local macrophages 
highly contribute to osteophyte formation during experimental OA
5,16
. Apart from growth 
factors, activation of synovial macrophages also results in production of the alarmins 
S100A8 and S100A9 [also known as myeloid-related protein (MRP)-8 and MRP-14, 
respectively]
17,18
. Recently, we showed that S100A8 and S100A9 are actively involved in 
cartilage damage and synovial activation during OA
19
. Moreover, we showed that these 
alarmins are involved in the process of ectopic bone formation; early symptomatic OA 
patients of the CHECK study with osteophyte progression had elevated plasma 
S100A8/S100A9 levels at baseline and in vivo models showed an involvement of 
S100A8/S100A9 in matrix metalloproteinases (MMP)-mediated osteophyte formation
20
. 
A study by Gierman et al. in 2012 showed a relation between metabolic stress and OA 
development in mice. A high-fat diet increased cartilage damage in aging mice
21
. More 
recently, the same group showed in the same model, that dietary cholesterol increased 
spontaneous cartilage damage
22
. 
Mice deficient of apolipoprotein E (ApoE) show naturally high levels of LDL-cholesterol 
independent of gender and age, that could additionally be increased by a cholesterol-rich 
diet
23
. ApoE, produced mainly by the liver and macrophages, is a transporter molecule 
important in clearance of chylomicrons, very low density lipoproteins and LDL remnants 
from the blood
24
. In the present study we specifically focus on the effects of increased 
cholesterol levels, by ApoE-deficiency or a cholesterol-rich diet, on inflammation, cartilage 
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damage and osteophyte formation during experimental OA. Furthermore, we investigate 
the role of the alarmins S100A8 and S100A9 in this cholesterol-driven OA pathology. 
Materials and methods 
Animals 
Wild type (WT) C57BL/6 mice and Apoe-deficient (Apoe
−/−
) B6.129P2-Apoe
tm1Unc
/J mice 
were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). MRP-14-deficient 
(S100a9
−/−
) mice in a C57BL/6 background were a kind gift of Dr. Hogg (Leukocyte Adhesion 
Laboratory, Cancer Research Institute, London, UK)
25
 and MRP-14/APOE double knockout 
(Apoe
−/−
S100a9
−/−
) mice were cross bred as described earlier
26
.
 
Mice (female, 10–16 weeks 
old at the start of the experiment) received food and water ad libitum and were housed in 
filter-top cages. Mice were fed a standard or cholesterol-rich diet (+0.15% cholesterol; AB 
Diets, Woerden, The Netherlands), starting 2 weeks before OA-induction until the end of 
the experiment. Experimental OA was induced by intra-articular injection of one unit 
bacterial collagenase (Sigma–Aldrich, St. Louis, MO, USA) into the right knee joint on day 
zero and day two
27
. On day 10 and day 36, mice were weighed and sacrificed. Both left and 
right knee joints were isolated for histological analyses or used for isolation of synovial RNA 
and wash-outs. Serum was obtained for colorimetric determination of cholesterol. All 
studies were approved by the Institutional Review Board (Animal Experiment Committee 
Radboud university medical center) and were performed according to the related codes of 
practice. 
Histology 
Knee joints were fixed in 4% buffered formalin and decalcified in formic acid. Joints were 
then embedded in paraffin and cut into 7-μm-thick representative sections of various 
depths. Sections were deparaffinized and stained with hematoxylin and eosin or Safranin O-
fast green for histological analysis. For immunohistochemistry, sections were incubated in 
Tris–ethylenediaminetetraacetic acid (Tris-EDTA; pH 9) at 60°C for antigen retrieval. 
Sections were washed with 0.025% Triton X-100 and incubated with rabbit anti-mouse 
S100A8 (produced as previously described
28
) or normal rabbit immunoglobulin G (IgG) 
(R&D Systems, Minneapolis, MN, USA) as control. Subsequently, endogenous peroxidase 
was blocked and sections were incubated with biotinylated goat anti-rabbit IgG, after which 
binding was detected using the avidin-biotin complex with horseradish peroxidase kit (Elite 
kit; Vector Laboratories, Burlingame, CA, USA). Peroxidase was developed with 
diaminobenzine (Sigma–Aldrich) and sections were counterstained with hematoxylin. 
Synovial thickening was measured using a 0–3 scoring system
29
 (0 = no synovial thickening; 
1 = lining of two cell layers; 2 = several extra cell layers; 3 = clear inflammation with cell 
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infiltrate or exudate). Three sections of various depths were scored per knee joint. Cartilage 
damage at the medial and lateral side of the tibia and femur was scored using the Pritzker-
OA-score
30
, adapted for mice (0–30, where 0 = no damage and 30 = maximal damage). Five 
sections of various depths (representing the entire knee joint) were scored per animal. Size 
of ectopic bone formation was measured by means of image analysis [Leica Application 
Suite (LAS) v4.1; Leica Microsystems, Wetzlar, Germany]. Areas of cartilage/bone-formation 
were manually circled by an investigator, after which the surface area was calculated by 
LAS-software. The mean cross-sectional surface area in three sections per knee joint was 
determined, including knee joints without ectopic bone formation. Synovial tissue was 
embedded in optimal cutting temperature (O.C.T.) compound (Sakura Finetic, 
Zoeterwoude, The Netherlands) for cryosectioning, stained for 60 min with Oil Red O 
(Sigma–Aldrich) and counterstained with hematoxylin. Lipid accumulation was scored using 
LAS image-processing software. All histology sections were randomly coded and scored in a 
blinded way by two independent investigators. 
 
Quantitative real-time polymerase chain reaction 
Synovial punches were taken up in TRIzol and RNA was extracted using the guanidinium 
thiocyanate–phenol–chloroform extraction as described by Chomczynski and Sacchi
31
. 
Isopropanol was used for precipitation. Messenger ribonucleic acid (mRNA) was reversed 
transcribed into complementary deoxyribonucleic acid (cDNA) using reverse transcriptase, 
oligo(dT) primers and deoxynucleotide triphosphate (dNTP) (Invitrogen, Carlsbad, CA, USA). 
Quantitative real-time polymerase chain reaction (qPCR) was performed using the 
StepOnePlus polymerase chain reaction system and StepOne software v2.3 (Applied 
Biosystems, Foster City, CA, USA). Conditions used were: 10 min 95°C, followed by 40 cycles 
of 15 s 95°C and 1 min 60°C. Data were collected during the last 30 s of each cycle. Product 
specificity was confirmed by assessment of dissociation-characteristics. A total of 10 μL 
reaction volume was used, containing 3 μL diluted cDNA, 1 μL forward primer (5 μM), 1 μL 
reverse primer (5 μM) and 5 μL SYBR Green Master Mix (Applied Biosystems). Primers were 
designed with Primer Express 2.0 (Applied Biosystems) and manufactured by Biolegio 
(Nijmegen, The Netherlands). Primers used were: mGapdh: 5′-GGCAAATTCAACGGCACA-3′ 
(forward) and 5′-GTTAGTGGGGTCTCGCTCCTG-3′ (reverse); mS100a8: 5′-
TGTCCTCAGTTTGTGCAGAATATAAAT-3′ (forward) and 5′-TTTATCACCATCGCAAGGAACTC-3′ 
(reverse); mS100a9: 5′-GGCAAAGGCTGTGGGAAGT-3′ (forward) and 5′-
CCATTGAGTAAGCCATTCCCTTTA-3′ (reverse). Expression levels were presented as −ΔCt, 
being the threshold cycle (Ct) value corrected for Gapdh. 
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Synovial wash-outs 
Synovial tissue was weighed and put in Roswell Park Memorial 
Institute medium (Gibco, Invitrogen), enriched with 
penicillin/streptomycin (100 units/mL potassium penicillin and 100 
μg/mL streptomycin sulfate; Lonza, Walkersville, MD, USA) and 0.1 
% bovine serum albumin (Sigma–Aldrich) for 1 h at room 
temperature. S100A8/A9-complexes were measured in the wash-
outs using sandwich enzyme-linked immunosorbent assay (ELISA), 
as described previously
32,33
. Keratinocyte chemoattractant (KC)-
protein levels were measured with Luminex-technology (Biorad, 
Hercules, CA, USA), using magnetic milliplex beads (Millipore, 
Billerica, MA, USA) according to the manufacture's protocol. 
 
Statistical analysis 
Statistical differences were tested using a two-tailed Student's t 
test (for comparison of two parametric variables; i.e., cholesterol 
levels, body weight, ectopic bone formation, gene expression and 
protein levels), Mann–Whitney test (for comparison of two non-
parametric variables; i.e., histological scores), or a one-way 
analysis of variance (ANOVA), followed by Dunnett's posttest (for 
comparison between more than two groups). All analyses were 
performed using Graph Pad Prism 5 (GraphPad Software, La Jolla, 
CA, USA) and P-values less than 0.05 were considered to be 
significant. Data are depicted as mean ± 95% confidence interval. 
Results 
APOE-deficiency increases synovial thickening and ectopic bone 
formation during experimental OA 
Previously, Gierman et al. reported that increased cholesterol 
levels could result in spontaneous cartilage damage in mice.
21
 To 
investigate whether high-cholesterol levels, independently of 
weight, could also aggravate other OA-associated pathology 
(including hallmarks such as ectopic bone formation and synovial 
activation), experimental OA was induced in 10–14 week-old WT 
and Apoe
−/−
 mice. Thirty-six days after OA-induction, knee joints 
and serum were collected for histological and serological analysis.  
68 
 
 
FIG 1. ApoE-deficiency increases synovial thickening and ectopic bone formation 36 days after OA-
induction 
Serum and histology were collected 36 days after collagenase-induced OA. A shows increased levels of 
LDL-cholesterol in Apoe
−/−
 compared with WT mice, while B shows no difference in body weight (at the 
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age of 20 weeks). Histological scoring showed increased synovial thickening in Apoe
−/−
 compared with 
WT mice (C). Cartilage damage was scored (D) and showed increased damage in ApoE
−/−
 mice at the 
lateral side of the femur but no differences on other surfaces. Increased ectopic bone formation in the 
medial collateral ligament of Apoe
−/− 
mice, was scored using image analysis software (E). n = 5 
(Apoe
−/−
) or 7 (WT) mice per group for cholesterol-measurements and n ≥ 16 mice per group for 
histology and body weight; data are presented as mean ± 95% confidence interval. 
 
Apoe
−/−
 mice showed very high plasma LDL levels (22 times increase, figure 1A) and more 
profound synovial lipid accumulation (supplemental figure 1) when compared with WT 
mice, whereas body weight did not differ (figure 1B). Synovial thickening, a measure for the 
amount of infiltrated cells and local proliferation, was markedly increased in Apoe
−/−
 mice 
when compared with WT mice (1.9 and 1.1, respectively; figure 1C) 36 days after OA-
induction. All four surfaces that were scored for cartilage damage showed moderate 
destruction (average 12.1 on a scale ranging from 0 to 30), indicative for an effective OA-
induction (supplemental figure 2A). At the lateral side of the femur, cartilage damage was 
higher in Apoe
−/−
 mice (13.7 ± 3.8) compared with WT mice (6.8 ± 2.4), whereas other 
cartilage surfaces showed comparable damage between the two groups (figure 1D). 
Next we investigated formation of ectopic bone in collateral and cruciate ligaments and at 
the margins of the bone. OA-induction in Apoe
−/−
 mice resulted in massive ectopic bone 
formation in the medial collateral ligament when compared with WT mice (5.4 times 
increase; figure 1E and lower magnification in supplemental figure 2B). In the patellar 
ligament, ectopic bone formation was only found in Apoe
−/−
 mice, whereas at the medial 
side of the femur, ectopic bone formation was profound in both Apoe
−/−
 and WT mice 
(figure 1E). 
cholesterol-rich diet increases synovial thickening in APOE-deficient mice and results in 
massive ectopic bone formation in both APOE-deficient and WT mice during experimental OA 
In addition, we investigated whether a cholesterol-rich diet could further increase joint 
pathology in both Apoe
−/−
 and WT mice during experimental OA. Mice were given a 
cholesterol-rich diet throughout the experiment, starting 18 days before OA-induction, 
based on studies by Ishibashi et al.
34
. Serum LDL levels in both WT and Apoe
−/−
 mice were 
more than doubled 36 days after OA-induction compared to earlier experiments where 
mice received a regular diet (table 1). Again, Apoe
−/−
 mice showed much higher LDL-
cholesterol levels than WT mice (18.4 mmol/L and 1.2 mmol/L, respectively; figure 2A), 
whereas weight did not differ (figure 2B). With an average OA-score of 16.8, overall 
cartilage damage was moderate to severe, however, no differences were found between 
WT and Apoe
−/−
 mice 36 days after OA-induction (figure 2C). Synovial thickening, on the 
other hand, was significantly increased in Apoe
−/−
 mice compared to WT mice 10 days after 
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induction of OA (figure 2D and E), while naïve (contra-lateral) joints of Apoe
−/−
 mice on a 
cholesterol-rich diet did not show any pathology (figure 2E). Thirty-six days after OA-
induction, synovial thickening in WT mice receiving a cholesterol-rich diet was markedly 
increased compared with the early time point, abrogating differences with Apoe
−/−
 mice 
(figure 2D). While ectopic bone formation at the medial collateral ligament, 36 days after 
OA-induction, was highly present in WT mice after a cholesterol-rich diet, it was not 
increased in Apoe
−/−
 mice. Although Apoe
−/−
 mice showed a trend towards more large-sized 
areas of ectopic bone at the margin of the medial side of the femur and medial collateral 
ligament, no significant differences were found compared to WT mice (figure 2F and G). 
A cholesterol-rich diet in Apoe
−/−
 mice results in early ectopic bone formation during 
experimental OA 
Thirty-six days after OA-induction, unexpectedly, we did not find significant differences in 
ectopic bone formation at the medial collateral ligament between Apoe
−/−
 and WT mice on 
a cholesterol-rich diet. Moreover, the average size of ectopic bone formation in Apoe
−/−
 
mice was not additionally increased in mice that received a cholesterol-rich diet. Since 
development of ectopic bone could already be maximal at this late time point, we 
investigated earlier stage OA. Ten days after induction of OA, we already saw proteoglycan 
deposition in both WT and Apoe
−/−
 mice that received a cholesterol-rich diet (red staining). 
Compared with WT mice, the area of proteoglycan deposition in the medial collateral 
ligament was significantly larger in Apoe
−/−
 mice (fold increase 2.6; figure 3) This suggests 
that, while on a cholesterol-rich diet, APOE-deficiency accelerates the formation of ectopic 
bone, resulting in large-sized structures already early during disease. 
APOE-deficiency increases synovial activation during collagenase-induced OA which is further 
enhanced with an additional cholesterol-rich diet 
In previous studies we have found that S100A8 and S100A9, released by activated 
synovium, are important factors in mediating cartilage damage and ectopic bone formation 
FIG 2. A cholesterol-rich diet increases synovial thickening in ApoE-deficient mice and results in 
tremendous ectopic bone formation in both Apoe
−/−
 and WT mice during experimental OA 
Mice received a cholesterol-rich diet, 18 days before induction of collagenase OA. The diet further 
increased serum LDL levels in Apoe
−/−
 mice (A), again not affecting body weight (B; 36 days after OA-
induction, at the age of 16 weeks). No differences between the two groups was found regarding 
cartilage damage (C), but synovial thickening in Apoe
−/−
 mice was increased 10 days after OA-
induction compared with WT mice (D and photomicrographs in E). Naïve joints of Apoe
−/−
 mice on a 
cholesterol-rich diet did not show any phenotype (E). Despite differences in LDL levels and synovial 
thickening at day 10, no differences in ectopic bone formation were found at day 36 (F). The panels in 
G show representative photomicrographs of ectopic bone formation in the medial collateral ligament 
of WT and Apoe
−/−
 mice on a regular and cholesterol-rich diet. n = 5 (Apoe
−/−
) or 7 (WT) mice per group 
for cholesterol-measurements and n ≥ 9 mice per group for histology and body weight; data are 
presented as mean ± 95% confidence interval. 
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during experimental OA
19
. Furthermore, we found that S100A8-expression in synovial lining 
was increased in WT mice after receiving a cholesterol-rich diet
11
. 
 
FIG 3. A cholesterol-rich diet in Apoe
−/−
 mice results in early pathology during experimental OA 
Ten days after collagenase-induced OA, increased area of proteoglycan deposition was found in 
Apoe
−/−
 mice on a cholesterol-rich diet (A and photomicrographs in B). n = 9 (Apoe
−/−
) or 10 (WT) mice 
per group; data are presented as mean ± 95% confidence interval. 
 
To investigate whether S100A8/S100A9 levels reflect the differences in pathology between 
WT and Apoe
−/−
 mRNA and protein levels were measured in synovial tissue and wash-outs, 
respectively, and visualized in synovium by immunohistochemistry. Both 10 days and 36 
days after onset of OA, synovia of Apoe
−/−
 mice on a standard diet showed increased mRNA 
expression of S100a8 and S100a9 (average 3-fold increase) compared with that of WT mice 
(figure 4A). Also protein levels in synovial wash-outs were significantly increased at the 
early time point (5.8 times increased in Apoe
−/−
 mice compared with WT mice). Thirty-six 
days after induction of OA, protein levels of S100A8/A9 in synovial wash-outs of Apoe
−/−
 
were still slightly higher than in WT mice, although these differences were not significant 
(figure 4B). Immuno-histochemical staining of S100A8 on sections of this late time point, 
however, showed increased S100A8-staining in synovial tissue of Apoe
−/−
 mice (figure 4C). 
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Next we investigated the expression of the alarmins S100A8 and S100A9 in WT and Apoe
−/−
 
mice, receiving a cholesterol-rich diet. Synovial mRNA expression of both proteins did not 
differ between WT and Apoe
−/−
 mice 10 days after OA-induction. At late-time-point OA, 
however, both S100a8 and S100a9 expression were significantly upregulated in Apoe
−/−
 
mice compared with WT mice (6.4 times and 2.3 times, respectively; figure 5A). Protein 
levels in synovial wash-outs of both WT and Apoe
−/−
 mice were relatively high compared to 
the levels of mice receiving a regular diet. Both at the early and late time point, Apoe
−/−
 
mice showed higher levels of S100A8/A9 compared with WT mice, however, these 
differences only reached significance 36 days after induction of OA (figure 5B). 
To investigate a possible mechanism for the observed synovial thickening and activation in 
Apoe
−/−
 mice, we measured chemokine-levels in the synovial wash-outs. Both 10 days and 
36 days after OA-induction, Apoe
−/−
 mice on a standard diet showed markedly higher levels 
of KC in wash-outs compared with WT mice (more than twice as high, P < 0.001; figure 4D). 
Monocyte chemotactic protein 1 (MCP-1) and macrophage inflammatory protein 1α 
(MIP1α) were not detected in the synovial wash-outs 10 days after OA-induction (data not 
shown). A cholesterol-rich diet increased KC levels, both in WT and Apoe
−/−
 mice (figure 5C). 
Ten days after OA-induction, a cholesterol-rich diet resulted in KC levels of 109 pg/mL/g 
synovium in WT mice and 139 pg/mL/g synovium in Apoe
−/−
 mice (3.8 and 2.1 times higher 
than with standard diet, respectively). Thirty-six days after induction of OA, KC was hardly 
detectable in WT mice on a cholesterol-rich diet, but extremely high in Apoe
−/−
 mice (5 
pg/mL/g synovium and 236 pg/mL/g synovium, respectively; P < 0.001). This further 
underlines the capacity of increased levels of cholesterol (either by APOE-deficiency or a 
cholesterol-rich diet) to activate the synovial lining during experimental OA. 
APOE-deficiency-induced synovial activation, but not ectopic bone formation, is mediated by 
S100A8/A9 
Recently, we reported that S100A8 and S100A9 are involved in ectopic bone formation
20
. 
Moreover, we know that S100A8 and S100A9 proteins act as prominent players in innate 
immunity and therefore play an important role in synovial activation
19,35
. To investigate 
whether the cholesterol-induced synovial activation and ectopic bone formation are 
mediated through S100-production, or S100-production is merely an effect induced by the 
observed pathology, we induced experimental OA in mice deficient for both APOE and 
S100A9 in combination with a cholesterol-rich diet. A mean OA-score of 20.1 at late-time-
point OA revealed a relatively severe OA in all groups (figure 6A), while naïve (contra-
lateral) knee joints showed no apparent pathology. Scoring ectopic bone formation 
revealed no significant differences between WT, APOE-deficient, S100A9-deficient and 
double knockout mice on all locations except for the medial collateral ligament (figure 6B).  
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FIG 4. Increased S100A8 and S100A9-production in Apoe
−/−
 mice during collagenase-induced OA 
Synovial tissue and wash-outs were collected 10 days and 36 days after collagenase-induced OA to 
investigate S100 expression. Both qPCR (A) and ELISA (B) show increased S100A8 and S100A9 
expression in ApoE
−/−
 mice, which was confirmed by immuno-histochemical staining for S100A8 as 
shown in the panels of C. Additionally, Luminex analysis showed increased KC production in Apoe
−/−
 
mice, both 10 and 36 days after OA-induction compared with WT mice (D). n = 8 mice per group; data 
are presented as mean ± 95% confidence interval. 
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FIG 5. S100A8/A9 levels during experimental OA are increased after a cholesterol-rich diet, and, together 
with KC-levels, are higher in Apoe
−/−
 mice compared with WT mice 
Thirty-six days after collagenase-induced OA, Apoe
−/−
 mice show higher expression of S100a8 and 
S100a9-mRNA in synovial tissue compared with WT mice (A). Also protein levels in wash-outs show 
significant differences at this time point (B). Luminex analysis in synovial wash-outs showed different 
levels of KC only at 36 days after OA-induction (C). n = 5 mice per group; data are presented as mean ± 
95% confidence interval. 
 
Again, we observed that, at the medial collateral ligament, WT mice and Apoe
−/−
 mice on a 
cholesterol-rich diet had comparable size of ectopic bone formation at late-time-point OA. 
S100a9
−/−
 mice on a cholesterol-rich diet showed less than half the amount of bone 
formation at this location (P < 0.05), confirming earlier studies in which we already showed 
that S100A8/A9 is involved in formation of ectopic bone
20
. Remarkably, mice deficient for 
both S100A9 and APOE did not show decreased ectopic bone formation at this location 
(figure 6B), suggesting that S100A8/A9 has no effect on ectopic bone formation in the 
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presence of high LDL levels. Focusing on the synovial part of this model, we see a slight 
increase in synovial thickening in the double knockout mice on a cholesterol-rich diet at the 
late time point (figure 6C), nevertheless, this difference did not reach significance, similar 
to what we found earlier in the APOE-single knockout at this time point (figure 2D).  
 
FIG 6. Cholesterol-induced OA pathology is partially mediated via S100A8/9 
Histology and KC-concentrations of synovial wash-outs at end-point OA in S100a9
−/−
Apoe
−/−
 mice. 
Panel A shows no difference in cartilage damage between the different groups. Ectopic bone 
formation at the medial collateral ligament was significantly decreased in S100a9
−/−
 mice, but not in 
double knockout mice (B). Although, on synovial thickening no significant differences were found (C), 
KC was increased in Apoe
−/−
 mice, but not double knockout mice (D). n = 13 mice per group for 
histology and n = 6 mice per group for synovial wash-outs; data are presented as mean ± 95% 
confidence interval. 
 
The concentration of KC, used here as the extent of synovial activation, again showed to be 
increased in Apoe
−/−
 mice compared with WT mice. In the double knockout mice, however, 
KC concentration in the synovial wash-outs was not increased compared to WT mice. These 
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results suggest that the increased synovial activation by high-cholesterol levels might be 
mediated by S100A8/S100A9 in contrast to ectopic bone formation which, under 
cholesterol-rich conditions, did not seem to be attenuated by S100A8/A9-deficiency. 
Discussion 
In this paper we show that increased levels of LDL induced by either a cholesterol-rich diet 
or APOE-deficiency, independently of body weight, result in synovial activation and ectopic 
bone formation during experimental OA. Previously we showed that increased cholesterol 
levels (in vivo) and macrophage-stimulation with oxidized LDL (in vitro), could induce 
activation of growth factors, such as TGF-β and BMPs
11
. Similarly, in the present study, 
induction of growth factors in cholesterol-rich conditions is apparent (supplemental figure 
2C) and a valid explanation for the observed increase of ectopic bone formation. 
High LDL levels hardly aggravated cartilage damage during collagenase-induced OA. This is 
in direct contrast with earlier studies in a spontaneous model, where cartilage damage was 
enhanced in cholesterol-rich conditions
21,22
. The difference between those studies and the 
present is that we actively induce OA. By inducing experimental OA via intra-articular 
collagenase-injection, we induce anabolic OA-like processes such as fibrosis and osteophyte 
formation, next to catabolic processes such as cartilage damage and inflammation. The 
complexity and balance of the different OA processes (anabolic vs catabolic) could 
influence basal outcome-parameters such as cartilage damage. An explanation could be the 
increased level of TGF-β within the synovium induced by high LDL levels. Studies have 
shown that anabolic factors such as TGF-β can protect cartilage against catabolic factors 
such as interleukin 1β, by restoring proteoglycan depletion
36
. 
One of the interesting findings of the present study is the location where ectopic bone 
formation is profoundly regulated. While ectopic bone formation is found in all joint 
ligaments and at the margins of the tibial plateau and femoral chondyles, cholesterol-
induced differences were particularly found within the medial collateral ligament. Since 
collagenase is injected at the femur-patella region and could therefore not account for this 
specific location, investigation of specific cell populations present in, or attracted to this 
area could give more insight into the reason why especially at this location ectopic bone 
formation is strongly enhanced. At this moment we are not certain how to explain this 
finding. Besides mechanical factors such as vulnerability to excessive loading at this 
particular location and differences in locomotor-activity, the balance between catabolic and 
anabolic processes could also differ per location. 
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Both our study in Ldlr
-/-
 mice
11
 and the present study show increased ectopic bone 
formation during cholesterol-rich conditions; however, the present study also shows 
differences in synovial thickening. Furthermore, production of S100A8/A9 and KC is more 
evident here. Recently, many studies focused on additional functions of APOE, next to 
cholesterol-transport. APOE has shown to have an anti-inflammatory function on 
macrophages
37
, as well as inhibit oxidation of LDL
38
. The lack of this anti-inflammatory 
function in Apoe
−/−
 mice could partly explain the differences we observe in synovial 
activation between WT and Apoe
−/−
 in this study, but also explain the lack of increased 
synovial thickening in the earlier study involving Ldlr
−/−
 mice. While the main focus of this 
study was the effect of enhanced cholesterol levels on OA pathology, it also gives rise to 
the possibility of involvement of APOE itself in mediating OA pathology. 
Based on the present study, we would like to emphasize that there are more systems than 
only growth-factor activation that seem to be affected by hypercholesteremia. Apparent in 
the present study is the association of enhanced cholesterol levels and high levels of 
S100A8/A9 during experimental OA. The synovium comprises macrophages, fibroblasts and 
endothelial cells. In OA, these cells become activated by released cartilage compounds, 
resulting in a smoldering synovitis. Up to 50% of OA patients exhibit synovial activation
39
. 
LDL is oxidized during inflammatory conditions
40,41
 and can be taken up by synovial cells via 
scavenger receptors
42-45
. Our study suggests that high levels of LDL (whether or not in the 
oxidized form) during experimental OA could indeed amplify activation of synovial cells, 
resulting in increased synovial thickening. S100A8 and S100A9 are important proteins in 
stimulating a variety of pathological processes during OA, such as synovial activation and 
ectopic bone formation. Earlier studies showed that mice deficient for S100A9 (and 
therefore also functionally knockout for S100A8
25,46
) had significantly reduced synovial 
activation
19
 and dramatically reduced osteophyte size
20
. Our present observation of 
increased expression of these proteins could, instead of the cause for, also be a result of 
increased pathology, as S100-proteins are being produced by macrophages in inflammatory 
conditions
47
. To further elucidate the role these proteins play in our model, we induced OA 
in mice deficient for both APOE and S100A9 in combination with a cholesterol-rich diet. 
What we observed was that ectopic bone formation at the medial collateral ligament did 
not differ between Apoe
−/−
S100a9
−/−
 and Apoe
−/−
 mice, while S100a9
−/−
 mice did show 
decreased ectopic bone formation. Although this confirms, as reported before
20
, an 
important role for S100A8/A9 in ectopic bone formation, it also suggests that ectopic bone 
formation induced under LDL-rich conditions during experimental OA is independent of 
S100A8/A9. Whereas S100-mediated osteophyte formation has been dedicated to MMP-
mediated cartilage matrix remodeling
20
, we expect cholesterol-induced osteophyte 
formation to be related to growth-factor activation
11
. The present study suggests that 
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ectopic bone formation by high-cholesterol levels supersede the reduced osteophyte 
formation by S100-deficiency. 
In contrast to ectopic bone formation, the increased levels of KC, that we repeatedly found 
in APOE-single knockout mice at late-time-point OA, were not observed in the double 
knockout mice. This suggests that S100A8/A9 does play a role in LDL-induced KC production 
and underlines the importance of S100-proteins for synovial activation in experimental OA 
under cholesterol-rich conditions. Possibly, activation of synovial cells by oxidized LDL 
(oxLDL) results in S100A8/A9 production, aggravating inflammation, subsequently resulting 
in KC production and cell influx. In general, our study shows that cholesterol levels can 
affect OA pathology and that S100A8/A9 levels are involved in some aspects of this 
pathology. 
In conclusion, we show that enhanced cholesterol levels aggravate ectopic bone formation 
and synovial activation in experimental OA, independently of weight. Therapies that focus 
on lowering cholesterol levels, or specifically block activation of synovial cells by (oxidized) 
LDL, are promising for modulation of OA pathology. Research into the direct mechanism of 
synovial activation by LDL will give more insight into the ethio-pathology of OA and could 
potentially be a step towards effective OA-treatment.  
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FIG S1. Lipid accumulation in synovium of Apoe
−/−
 mice is more pronounced than in WT synovium 
Cryosections of synovia from mice on a standard diet were stained with Oil Red O for 60 min and 
counterstained with hematoxylin as a measure for lipid accumulation. Synovium of Apoe
−/−
 mice 
showed more pronounced red staining compared to that of WT, confirming a relation between 
increased serum levels of cholesterol and lipid accumulation in synovium. n = 3 mice per group; data 
are presented as mean ± 95% confidence interval. 
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FIG S2. Ectopic bone formation during experimental OA in the medial compartment is more apparent in 
Apoe
−/−
 mice than in WT mice, while cartilage damage is comparable 
A shows representative photomicrographs of cartilage damage 36 days after collagenase-induced OA 
from mice on a standard diet. Full joint pictures highlight drastic differences in ectopic bone formation 
between medial and lateral compartments (B). Under OA-conditions, synovial wash-outs of Apoe
−/−
 
mice showed more TGF-β activity than wash-outs of WT mice, as measured by reporter gene assay (C). 
n = 8 mice per group; data are presented as mean ± 95% confidence interval. 
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Abstract 
Objective 
LDL in inflamed synovium is oxidized and taken-up by synoviocytes. In this study, we 
investigate whether direct injection of oxLDL into a normal murine knee joint induces joint 
pathology and whether synovial macrophages are involved in that process. 
Methods 
Synovium was obtained from end-stage OA patients in order to analyze LDL-uptake. Murine 
knee joints were injected five consecutive days with oxLDL, LDL, or vehicle (PBS). This 
procedure was repeated in mice depleted of synovial macrophages by intra-articular 
injection of clodronate liposomes seven days prior to the consecutive injections. Joint 
pathology was investigated by immunohistochemistry, flow cytometry (FCM) and synovial 
RNA expression and protein production. 
Results 
Synovial tissue of OA patients showed extensive accumulation of apolipoprotein B. Multiple 
injections of oxLDL in murine knee joints significantly increased TGF-β activity in synovial 
wash-outs, but did not induce catabolic or inflammatory processes. In contrast, repeated 
injections of oxLDL in macrophage-depleted knee joints led to increased synovial thickening 
in combination with significantly upregulated protein and RNA levels of CCL2 and CCL3. 
FCM-analyses revealed increased presence of monocytes and neutrophils in the synovium, 
which was confirmed by immunohistochemistry. Also protein levels of S100A8/A9 were 
significantly increased in synovial wash-outs of oxLDL-injected joints, as was expression of 
aggrecanase-induced neo-epitopes. Interestingly, no raise in TGF-β concentrations was 
measured in macrophage-depleted joints. 
Conclusions 
OxLDL can affect joint pathology, since synovial macrophages promote anabolic processes 
after oxLDL injections. In absence of synovial macrophages, however, oxLDL induces 
production of pro-inflammatory mediators and aggrecanase activity combined with 
increased influx of monocytes and neutrophils. 
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Introduction  
Osteoarthritis (OA) is the most common form of arthritis world-wide, affecting almost 14% 
of the adults aged 25 years and older in the US
1
. With hallmarks such as cartilage 
destruction, bone changes and synovial inflammation, it is seen as a disease of the entire 
joint, affecting cartilage, bone, ligaments and joint lining. As of yet, no curative therapy 
exists for OA, and patients are only treated with pain medication, anti-inflammatory drugs 
and, ultimately, whole joint replacement. A substantial part of OA patients develops 
synovial activation and we previously showed that synovial lining macrophages play a 
crucial role in driving joint pathology, such as cartilage damage and ectopic bone 
formation
2-4
. The metabolic syndrome is a term for a combination of pathological processes 
that increase cardiovascular risks such as hypertension, diabetes, obesity and high levels of 
low-density lipoproteins (LDL). It has extensively been associated to OA, but the exact 
mechanistic relation remains unknown
5,6
. 
S100A8 and S100A9 (also known as myeloid-related protein (MRP-)8 and MRP-14, 
respectively) are endogenous TLR4 ligands produced by granulocytes, monocytes and 
activated macrophages. Intracellularly, these proteins are involved in calcium homeostasis, 
but they show strong pro-inflammatory properties when extracellularly released
7
. 
Previously, we showed that high LDL levels can aggravate OA pathology by inducing ectopic 
bone formation and production of S100A8 and S100A9, the latter resulting in increased 
synovial activation and production of damage-inducing proteins. We hypothesized that this 
is caused by increased oxidation of LDL
8,9
. 
Oxidation of LDL has been studied extensively in relation to cardiovascular diseases
10
. 
Consensus exists that oxidized LDL (oxLDL) is one of the most potent initiators of 
atherosclerosis
11,12
. Increased levels of oxLDL have shown to lead to production of catabolic 
enzymes, inflammatory mediators and growth factors
13,14
. It initiates production of 
chemoattractants and potentiates differentiation of monocytes into macrophages
15
. 
Recently, we postulated that low grade inflammation during OA could induce local 
oxidation of LDL, activating synovial cells and thereby aggravating OA pathology
16
. Synovial 
fluid (SF) contains LDL
17
, but synovium is also highly vascularised. Either serum- or SF-
derived LDL could be oxidized under inflammatory conditions and taken up by synovial 
cells
18
. 
In this paper, we study the interaction of oxLDL with synovial lining macrophages and other 
synovial cells and investigate its effect on joint pathology. We inject oxLDL directly into the 
knee joint and we compare pathology induced by injection of oxLDL to that of knee joints 
injected with native (non-oxidized) LDL.  
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Methods 
Patient material 
Synovial tissue was obtained from twelve individual OA patients. Patients were diagnosed 
end-stage OA and joint tissue was obtained during knee arthroplasty, including resection of 
the synovium, and anonymized. Synovial tissue was identified microscopically and isolated 
for histochemical processing. Human oxLDL and LDL were isolated from healthy volunteers 
and prepared with informed consent as described previously.
8
 
Animals 
Wild type (WT) C57BL/6 mice and apolipoprotein E-deficient (apoe
-/-
) B6.129P2-apoe
tm1Unc
/J 
mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). Mice (10 to 13 
weeks old) were housed in filter-top cages and received food and water ad libitum. Animal 
studies were approved by the Institutional Review Board and were performed according to 
the related codes of practice. 
Mice were depleted of synovial lining macrophages by intra-articular injection of 6 μL 
clodronate liposomes (ClodronateLiposomes.org, Amsterdam, the Netherlands) seven days 
prior to performing experiments. Liposomes filled with phosphate buffered saline (PBS; 
ClodronateLiposomes.org) were injected as control. Mice were injected 5 consecutive days 
with 6 μL oxLDL (1.2 mg/mL), LDL (1.2 mg/mL) or vehicle (PBS), all in combination with 10 
μg/mL polymyxine B sulfate (PMB; Sigma-Aldrich, St. Louis, MO, USA) to rule out endotoxin 
effects and sacrificed two days after the last intraarticular injection.  
Histological and immunohistochemical preparation 
Human synovial tissue and murine knee joints were fixed, decalcified and embedded in 
paraffin as described before.
8
 Sections were stained with H&E for histological analysis. For 
immunohistochemistry, sections were digested with proteinase-free chondroitinase ABC 
(0.25 units/mL in 0.1 M Tris-HCL pH 8.0; Sigma-Aldrich) and endogenous peroxidase activity 
was blocked using 1% H2O2 in methanol. Slides were then incubated in buffered citrate (pH 
6.0), followed by cell membrane permeabilization with 0.1% Triton X-100 (Scharlau, 
Sentmenat, Spain). Sections were incubated with rabbit anti-mouse S100A8 or S100A9, 
produced as described earlier
19
, goat anti-human apolipoprotein B (apoB; Abcam, 
Cambridge, UK), affinity-purified rabbit anti-VDIPEN or rabbit anti-NITIGE IgG (kindly 
provided by J. Mort, Shriners Hospital for Children, Montreal, Canada), NIMP.R14 (kindly 
provided by M. Strath, National Institute for Medical Research, London, United Kingdom) or 
a suitable IgG-control (R&D Systems, Minneapolis, MN, USA). Subsequently, sections were 
incubated with a second antibody and binding was detected using the ABC-HRP kit (Elite 
Kit; Vector Laboratories, Burlingame, CA, USA). Peroxidase was developed with 
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diaminobenzidine (DAB; Sigma-Aldrich) and sections were counterstained with hematoxylin 
or orange G (2%). Sections were randomly coded and scored in a blinded way by two 
independent investigators. 
ApoB presence in two specific areas of the human tissue samples (synovial lining layer and 
area adjacent to blood vessels) was scored ‘positive’ when more than 50% of the cells were 
positively stained (compared to the isotype control) and ‘negative’ when more than 50% of 
the cells were comparably stained to the same area in the isotype control. 
Synovial thickening was analyzed using a scoring system from 0 to 3 (0 = no synovial 
thickening; 1 = lining of two cell layers; 2 = several extra cell layers; 3 = clear inflammation 
with cell infiltrate or exudate) adapted from Krenn et al.
20
 Immunohistochemical staining 
was analyzed using a comparable system (were 0 = no staining and 3 = excessive staining) 
as suggested by Glasson et al.
21
 Three sections of various depths were scored per knee 
joint. 
Synovial wash-outs 
Synovium was isolated from murine knee joints using a standardized method comprising 
removal of the quadriceps and section of the patella ligament as described previously by 
Lubberts et al.
22
  Tissue was put in Roswell Park Memorial Institute medium (Gibco, 
Invitrogen, Carlsbad, CA, USA), enriched with 48 μg/mL gentamicin (Centrafarm, Etten-Leur, 
the Netherlands) and 0.1% BSA (Sigma-Aldrich) for one hour at room temperature. Prior to 
incubation, two 3 mm biopsies were taken for RNA isolation. 
Flow cytometry of synovial cells 
Single cell suspensions of synovia were prepared following enzymatic digestion as 
previously described.
23
 Synovial cells were analyzed by flow cytometry (FCM; supplemental 
figure 1) and neutrophils were identified as CD11b
hi
 (CD90/B220/CD49b/NK1.1/Ly6G)
hi
 
(F4/80/I-A
b
/CD11c)
lo
 Ly6C
int
 SSC
hi
 and monocytes as CD11b
hi
 
(CD90/B220/CD49b/NK1.1/Ly6G)
lo
 (F4/80/I-A
b
/CD11c)
lo
 Ly6C
hi/lo
 SSC
int
 as previously 
described.
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Protein measurements 
Murine S100A8/A9 complexes were measured as described previously, using sandwich 
ELISA.
25,26
 Protein levels of chemokine (C-C motif) ligand 2 (CCL2), CCL3 and chemokine (C-
X-C motif) ligand 1 (CXCL1) were determined using Luminex multianalyte technology with 
Multiplex magnetic beads (Millipore, Billerica, MA, USA) according to the manufacturers 
protocol and measured with the Bio-Plex system (Bio-Rad, Veenendaal, the Netherlands). 
Active TGF-β and BMP signalling was measured using a CAGA- or BRE-Luciferase reporter 
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plasmid, respectively, kindly provided by P. ten Dijke (Leiden University Medical Center, the 
Netherlands), as described before.
8
 Protein levels were corrected for synovial weight. 
Quantitative real-time polymerase chain reaction 
RNA was extracted from synovium using the single step RNA isolation method described by 
Chomczynski and Sacchi and transcribed into complementary DNA (cDNA).
21
 Quantitative 
real-time polymerase chain reaction was performed using the StepOnePlus Real-Time PCR 
system and StepOne software v2.3 (Applied Biosystems, Foster City, CA, USA), under 
conditions described previously.
5
 The following primers (spanning the exon-exon junction) 
were designed with Primer Express 2.0 (Applied Biosystems) and manufactured by Biolegio 
(Nijmegen, the Netherlands). mCcl2: 5’-ttggctcagccagatgca-3’ (forward) and  5’-
cctactcattgggatcatcttgct-3’ (reverse);  mCcl3: 5’-caagtcttctcagcgccatatg-3’ (forward) and 5’-
tcttccggctgtaggagaagc-3’ (reverse); mCxcl1: 5’-tggctgggattcacctcaa-3’ (forward) and 5’-
gagtgtggctatgacttcggttt-3’ (reverse); mGapdh: 5’-ggcaaattcaacggcaca-3’ (forward) and 5’-
gttagtggggtctcgctcctg-3’; mIL-1b: 5’-ggacagaatatcaaccaacaagtgata-3’ (forward) and 5’-
gtgtgccgtctttcattacacag-3’ (reverse); mIL-6: 5’-caagtcggaggcttaattacacatg-3’ (forward) and 
5’-attgccattgcacaactcttttct-3’ (reverse); mIL-10: 5’-atttgaattccctgggtgagaa-3’ (forward) 
and 5’-acaccttggtcttggagcttattaa-3’ (reverse); mS100a8: 5’-tgtcctcagtttgtgcagaatataa 
at-3’ (forward) and 5’-tttatcaccatcgcaaggaactc-3’ (reverse); mS100a9: 5’-ggcaaag 
gctgtgggaagt-3’ (forward) and 5’-ccattgagtaagccattcccttta-3’ (reverse); mTgfb1: 5’-
gcagtggctgaaccaagga-3’ (forward) and 5’-aagagcagtgagcgctgaatc-3’ (reverse). Expression 
levels were presented as the threshold cycle corrected for Gapdh (–ΔCt).  
Statistical analysis 
Differences were tested using a student’s t-test or a one-way analysis of variance (ANOVA), 
followed by Dunnett’s posttest. Analyses were performed using Graph Pad Prism 5 (La Jolla, 
CA, USA) or SPSS Statistics version 22.0.0.1 (IBM Corporation, Armonk, NY, USA) and P-
values less than 0.05 were considered to be significant. Data are depicted as mean ± 95% 
confidence interval. 
Results 
Apolipoprotein B is differentially expressed in human osteoarthritic synovium 
OA is associated with the metabolic syndrome, which includes high cholesterol levels. We 
hypothesize that (modified) LDL could play a role during OA pathology by activating 
synovial cells. Therefore, we first investigated whether LDL/oxLDL is present in human 
synovial cells during OA. 
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We visualized the expression of apoB (the main protein in LDL and oxLDL particles) in 
anonymized synovium derived from OA patients undergoing arthroplasty. 
Immunohistochemistry shows presence of apoB in synovium from 9 out of 12 OA patients. 
ApoB was detected in both synovial lining (figure 1A, black arrows) and endothelial cells 
(figure 1A, yellow arrows). A clear difference in apoB-topography, however, was observed 
between patients. While two out of twelve patients showed intense staining of only the 
synovial lining layer (17%), three showed apoB expression only in endothelial cells (25%). 
Four patients showed apoB expression in both synovial lining and endothelial cells (33%). 
Closer examination revealed apoB-presence in different types of synoviocytes based on 
 
FIG 1. Apolipoprotein B is present in human osteoarthritic synovium 
Synovial tissue obtained from 12 OA patients was stained against human apoB (A). ApoB was clearly 
expressed in synovial lining (black arrows) and endothelial cells (yellow arrows) of most patients. B 
shows detailed photomicrographs of apoB-accumulation in fibroblasts, macrophages, and directly 
alongside blood vessels. 
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morphology (figure 1B). These data confirm presence of low-density lipoproteins in human 
OA synovium.  
Repeated intra-articular injections of oxLDL do not induce inflammation, but promote 
production of active TGF-β 
Apart from having effect on pro-inflammatory cytokines, oxLDL may also have effect on the 
production of anabolic mediators. Important anabolic factors present within the OA joint 
are TGF-β and BMP. Gene expression of Bmp2, 4, 6, 7 and 9 as well as protein levels of 
BMPs were not regulated after injection of LDL or oxLDL (data not shown). While regulation 
of the Tgfb1 gene was also not found (figure 3A), intra-articular injections with oxLDL 
significantly increased levels of active TGF-β from 16562 relative light units (RLU) to 21151 
RLU (figure 3B), as measured by functional TGF-β reporter gene assay, suggesting activation 
of latent TGF-β. In our previous study we found that systemic high levels of LDL aggravate 
OA pathology in a murine model, but we had insufficient evidence to link this specifically to 
oxLDL and to distinguish between systemic and local effects.
8
 To investigate the direct 
effect of oxLDL on joint pathology development, mouse knee joints were injected five 
consecutive days with vehicle (PBS), LDL or oxLDL (all in combination with PMB). 
Histological analysis showed that multiple injections of PBS led to mild thickening of the 
synovial lining layer (score of 1.1), which, however, did not significantly differ after LDL and 
oxLDL injection (figure 2A). Messenger RNA levels of S100a8 and S100a9, markers for 
synovial macrophage activation
28
, showed no altered expression after injection of LDL or 
oxLDL when compared to PBS injection (figure 2B). This was confirmed by 
immunohistochemistry for S100A8, which showed only minimal number of S100A8 positive 
cells after multiple injections (figure 2C). Moreover, S100A8/A9 concentrations in synovial 
wash-outs after multiple injections of PBS were relatively low (2.7 μg/mL/g synovium) and 
were not increased by LDL injection and even significantly lowered after oxLDL injection by 
almost 50% (figure 2D). Gene expression levels of interleukins (IL)-1β, IL-6 and IL-10 and 
chemokines CCL2, CCL3 and CXCL1, known to be important in regulating inflammation, 
were not found to be altered after (ox)LDL-injection (data not shown). 
Apart from having effect on pro-inflammatory cytokines, oxLDL may also have effect on the 
production of anabolic mediators. Important anabolic factors present within the OA joint 
are TGF-β and BMP. Gene expression of Bmp2, 4, 6, 7 and 9 as well as protein levels of 
BMPs were not regulated after injection of LDL or oxLDL (data not shown). While regulation 
of the Tgfb1 gene was also not found (figure 3A), intra-articular injections with oxLDL 
significantly increased active TGF-β signaling by 28% (figure 3B), as measured by functional 
TGF-β reporter gene assay, suggesting activation of latent TGF-β. 
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Next, we investigated formation of aggrecanase-induced (NITEGE) and metalloproteinase-
induced (VDIPEN) neo-epitopes of aggrecan using immunolocalization with specific 
antibodies.  
 
 
FIG 2. Repeated injections of oxLDL in murine joints do not cause activation of the synovial lining 
 Mice were injected five times with PBS, LDL or oxLDL, after which histological sections were stained 
with H&E and scored (A). Figure B shows no regulation S100a8 and S100a9 (RNA expression corrected 
for Gapdh), nor were any effects found on immunohistochemistry for S100A8 (C). S100A8/9 protein 
levels in synovial wash-outs was decreased after injection of oxLDL (D). Statistics were performed 
using a one-way ANOVA followed by Dunnett’s posttest. n = 9 mice per group for histology and n = 8 
mice per group for RNA expression and synovial wash-outs. 
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FIG 3. OxLDL injection enhance anabolic and decrease catabolic processes 
While RNA expression of synovium did not show increased regulation of TGF-β (A), synovial wash-outs, 
tested in a functional TGF-β reporter gene assay (CAGA-Luciferase reporter plasmid), showed 
increased presence of active TGF-β in oxLDL injected joints (B). Immunohistochemistry for NITEGE (C) 
and VDIPEN (E) shows decreased expression in cartilage adjacent to synovial tissue after injection of 
oxLDL. Figures D and F show representative photomicrographs including isotype control. Statistics 
were performed using a one-way ANOVA followed by Dunnett’s posttest. n = 8 mice per group for 
synovial wash-outs and RNA expression and n = 4 mice per group for histology. 
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Although, we found low expression of these neo-epitopes within the cartilage (after intra-
articular injection of PBS a score of 1.2 for NITEGE and 0.9 for VDIPEN), oxLDL injection 
showed a strong trend towards reduced NITEGE staining (figure 3C and D) as well as 
VDIPEN staining compared to injection with LDL (figure 3E and F), especially in areas along 
the bone margins that are prone to develop osteophytes. 
Injection of oxLDL, not LDL, after depletion of synovial lining macrophages results in synovial 
activation, rather than promoting anabolic processes 
Since, in a normal joint, oxLDL is scavenged by macrophages, we next investigated oxLDL 
injection into macrophage-depleted joints. H&E staining showed complete depletion of 
synovial lining cells (figure 4B). Whereas repeated LDL injections did not significantly affect 
synovial thickness compared to PBS controls, repeated injections of oxLDL led to a 5.3 fold 
increase of synovial thickening compared to injection with LDL (figure 4A and B). Moreover, 
mRNA-expression of S100a8 and S100a9 was 4.6 fold and 5.7 fold increased, respectively, 
after injection of oxLDL compared to injection with PBS (figure 4C and D). In line with this, 
protein levels of S100A8/A9 were significantly increased in synovial wash-outs of oxLDL 
injected joints, compared to LDL or PBS injected joints (20.1 μg/mL/g synovium, 3.6 
μg/mL/g synovium and 2.4 μg/mL/g synovium, respectively; figure 4E). This was confirmed 
by immunohistochemistry for S100A8 and S100A9, which clearly showed S100-expressing 
cells in the synovial lining after repeated injections of oxLDL in macrophage-depleted joints, 
which was not seen after LDL injection (figure 4F). 
We next investigated the effect of local macrophage depletion in a mouse with naturally 
high synovial LDL levels that are comparable to the amounts injected (approximately 1.4 
mg/mL). Mice lacking ApoE are incapable to effectively clear LDL cholesterol from 
circulation, resulting in increased LDL-accumulation in blood and synovium, without 
affecting body weight.
9
 ApoE-deficient mice were intra-articularly injected with clodronate 
liposomes to deplete synovial macrophages. Two weeks after lining-depletion, 
macrophage-depleted joints only showed minimal pathology which was comparable to that 
of non-macrophage-depleted joints and joints of WT mice (supplemental figure 2). This 
confirms that merely high natural levels of LDL are not able to induce the pathology in 
absence of oxidative triggers such as inflammation. 
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FIG 4. OxLDL injection in macrophage depleted joints leads to synovial thickening and S100A8/9 
production 
Synovial lining macrophages were depleted by intra-articular injection of clodronate liposomes. 
Subsequent injection of oxLDL led to increased synovial thickening (A). B shows representative H&E 
stained photomicrographs. Quantitative real-time PCR analysis showed increased expression of 
S100a8 (C) and S100a9 (D) after oxLDL injection. In addition, protein levels of S100A8/A9 were 
significantly increased in synovial wash-outs (E). F shows representative pictures of 
immunohistochemical staining for S100A8 and S100A9, including isotype control. Statistics were 
performed using a one-way ANOVA followed by Dunnett’s posttest. n = 9 mice per group for histology 
and n = 8 mice per group for RNA expression. 
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Multiple oxLDL injections, after depletion of synovial lining macrophages, result in increased 
influx of myeloid cells 
In order to explain the cell influx observed in macrophage-depleted joints after injection of 
oxLDL, we investigated gene expression of important chemokines. While in normal 
(macrophage-containing) joints expression of Ccl2, Ccl3 and Cxcl1 was not regulated, oxLDL 
injection in macrophage-depleted knee joints induced significant upregulation by 6.7 fold 
for Ccl2 and 4.7 fold for Ccl3 compared to PBS and LDL injections, which was confirmed by 
measuring protein levels in synovial wash-outs (figure 5A and B). Protein levels of CXCL1 
were found to be significantly higher in oxLDL-injected, macrophage-depleted synovial 
wash-outs. 
Cxcl1, however, was not found to be regulated on RNA-level by oxLDL injection (figure 5C), 
suggesting a different source for production than synovial cells. Closer examination of the 
cell influx in H&E-stained slides showed influx of both mononuclear and 
polymorphonuclear cells. Further analysis of these cells by FCM revealed that there is an 
increased amount of monocytes present in synovium of oxLDL-injected joints after 
macrophage depletion compared to PBS injected joints (3029 and 1422, respectively). Also 
analysis of the neutrophil population showed an increased cell number after injection of 
oxLDL from 4014 to 12708 (figure 5D). Staining for NIMP.R14, a specific stain for 
polymorphonuclear granulocytes (PMN) but not monocytes
29
, confirmed both the presence 
of PMN and mononuclear myeloid (unstained) cells (figure 5E). 
We next investigated whether oxLDL injection into macrophage-depleted joints still 
resulted in enrichment of anabolic processes. We therefore tested synovial wash-outs of 
macrophage-depleted joints and found that repeated injections of oxLDL did not affect the 
levels of active TGF-β (figure 6A) in contrast to repeated injections in knee joints where 
macrophages were present (figure 3A). Moreover, where VDIPEN expression (figure 6B) 
showed a similar pattern compared to normal knee joints (figure 3E and F), we found a 
significant increase in NITEGE staining if we compared oxLDL with LDL and vehicle injections 
(scores 1.4, 0.5 and 0.8, respectively; figure 6C and D); opposite to what we observed in 
normal knee joints (figure 3C and D).  
FIG 5. OxLDL injections in macrophage-depleted joints lead to cell attraction 
Injection of oxLDL in macrophage-depleted knee joints results in increased production of CCL2 (A), 
CCL3 (B) and CXCL1 (C). FCM-analysis revealed increased amounts of monocytes and neutrophils in the 
synovium (D), which was confirmed by immunohistochemical staining, showing infiltrating cells both 
positively and negatively stained for NIMP.R14 (photomicrographs in E, including isotype control), 
while. Statistics were performed using a one-way ANOVA followed by Dunnett’s posttest (for PCR and 
protein measurements) or a student’s t-test (for FACS data). n = 8 mice per group. 
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FIG 6. In the absence of lining macrophages, oxLDL injections increase expression of neo-epitopes of 
aggregenases 
After depletion of macrophages, repeated oxLDL injections did not increase the amount of active TGF-
β in synovial wash-outs (A). Although oxLDL injection showed a trend towards decreased VDIPEN 
expression (B), it significantly increased expression of NITEGE (C, with representative 
photomicrographs in D). Statistics were performed using a one-way ANOVA followed by Dunnett’s 
posttest. n = 8 mice per group for synovial wash-outs and n = 4 mice per group for histology. 
Discussion 
In this paper, we show that murine synovial macrophages induce anabolic processes after 
stimulation with oxLDL, not LDL. In the absence of synovial macrophages, oxLDL is able to 
induce joint pathology such as inflammatory and catabolic processes. 
The association between cholesterol levels and OA pathology has long been suggested, but 
is limited to associative and indirect evidence.
16
 LDL has been reported to be abundantly 
present in SF of OA patients (450 μg/mL)
17
 and we show in the present study that apoB, the 
main protein in LDL and oxLDL, is also present in various synovial cells of OA patients 
including macrophages. In our previous studies, we coupled high systemic levels of LDL in 
mice to OA-pathology
8,9
, but could not make a distinction between systemic and local 
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effects or link observed pathology specifically to oxidized LDL. Therefore, in this paper, we 
directly injected LDL and oxLDL into murine knee joints to investigate local effects.  
OxLDL is mainly taken up by scavenger receptor A (SR-A)
30
, CD36
31
 and lectin-like oxLDL 
receptor 1 (LOX-1)
32
. Macrophages express all three types of receptors, of which SR-A is 
thought to have the highest affinity for oxLDL.
33
 In a recent study, we showed that high 
systemic levels of cholesterol in mice led to increased ectopic bone formation in the knee 
joint during experimental OA and increased presence of active TGF-β in synovial wash-outs. 
Additionally, stimulation of bone marrow derived macrophages with oxLDL leads to 
significantly increased levels of active TGF-β.
8
 From these data we already postulated a role 
for specifically oxLDL-uptake by macrophages in driving anabolic processes during OA, but 
lacked direct in vivo evidence. We now have data that support our hypothesis that oxLDL 
presence in normal murine knee joints directly coincides with increased levels of active 
TGF-β. The fact that we do not detect differences in TGF-β gene expression, hints towards 
an mechanism by which oxLDL is activating latent TGF-β, rather than increasing TGF-β 
production.  
An interesting finding in our study was that, in human OA synovium, we see uptake of 
(modified) LDL not only by macrophages, but also by endothelial cells and fibroblasts. To 
investigate the effects of oxLDL on synovial cells other than macrophages, we selectively 
depleted macrophages before injecting oxLDL. To remove specifically macrophages from 
the synovium, clodronate-containing liposomes were injected into the knee joint, seven 
days prior to oxLDL injections. Clodronate liposomes are selectively taken up by synovial 
lining macrophages. Once inside the cell, the clodronate is released and induces cell 
apoptosis without affecting surrounding synovial cells.
34
 Interestingly, oxLDL no longer 
seemed to induce anabolic processes, but rather initiated inflammation and expression of 
aggrecanases as measured by NITEGE neo-epitopes; key players in the development of OA 
damage. This process could be relevant in OA patients that have an excess of oxLDL, leading 
to saturation of synovial macrophages, or when fibrosis is stimulated by the OA process 
which often coincides with loss of macrophages. Interestingly, we could not find significant 
gene regulation of aggrecanases and did not detect MMP-expression (data not shown), but 
we previously showed that monocytes can develop a pro-inflammatory phenotype after 
training by oxLDL.
35
 Furthermore, inflammatory factors such as toll-like receptor 4 ligands 
(e.g. S100A8) could change receptor balances in the synovium, changing affinity of different 
cell types to take up oxLDL.
36
  
Uptake of oxLDL by endothelial cells via LOX-1 has shown to induce expression of adhesion 
molecules and CCL2
37
, while uptake of oxLDL by fibroblast has shown to result in 
production of metalloproteinases 1 and 3
38
. The present data gives insufficient evidence to 
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conclude which cells are important for the pro-inflammatory and catabolic processes we 
observe, but, nevertheless, hints toward a dual role for oxLDL in which scavenging by lining 
macrophage induces TGF-β and prevents activation of cells that would otherwise result in 
degenerative processes. Furthermore, the observed activation of TGF-β after repeated 
injection of oxLDL in the presence of macrophages, could induce a protective phenotype 
which actively suppresses potential catabolic effects. This is in line with earlier studies in 
which we showed that TGF-β can be protective for catabolic processes by restoring 
proteoglycan depletion.
39
  
Overall, oxLDL is a factor capable of affecting joint pathology and could be an important 
player in OA. The net effect of high oxLDL levels on joint pathology will, in the end, depend 
on receptor balances and cell heterogeneity of OA synovium: end-stage OA fibrotic 
synovium
40,41
 could skew the balance towards catabolism, while low grade inflammation 
during early OA
42
 could promote anabolism as we saw earlier in our animal models.
8,9
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FIG S1. Synovial influx of both monocytes and neutrophils, as analyzed by flow cytometry 
Gating-strategy used for FCM analysis. 
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FIG S2. Naturally high levels of LDL alone, in absence of macrophages, do not induce pathology 
Clodronate-containing liposomes were injected in WT and apoe
-/-
 mice to test the capability of high 
levels of LDL to induce OA-like pathology in the absence of synovial lining macrophages. Histology 
revealed no differences in synovial thickening (A) or cartilage destruction (B) between WT and apoe
-/-
 
mice, both in naïve and macrophage-depleted joints. C shows representative pictures of the synovial 
lining of naïve WT and apoe
-/-
 mice in presence and absence of synovial macrophages. n = 6 mice per 
group. 
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Abstract 
Introduction 
Apolipoprotein E (APOE) is mainly known for its role in cholesterol metabolism. Recent 
studies, however, have shown that this molecule is also capable of suppressing innate 
immunity responses. In humans different polymorphisms of APOE exist, all with different 
anti-inflammatory efficacies. A role for APOE-isoform APOε4 in innate immune diseases 
such as Alzheimer’s disease and multiple sclerosis has already been described. In this study 
we investigated whether APOE polymorphisms could also play a role during inflammatory 
osteoarthritis (OA) by comparing disease severity in mice transgenic for human APOε3 and 
APOε4 in an experimental OA model. 
Methods 
Inflammatory OA was induced by injection of collagenase in knee joints of B6.129P2-
Apoe
tm2(APOE*3)Mae
N8 (APOε3) and B6.129P2-Apoe
tm3(APOE*4)Mae
N8 (APOε4) mice. Forty-two 
days after OA-induction knee joints were isolated and synovial thickening, cartilage 
destruction and osteophyte formation was measured using histology and image analysis. 
Results 
Naïve knee joints of APOε3 and APOε4 mice showed no abnormalities, nor were there any 
histological differences between the two groups. After induction of OA, APOε4 mice 
developed significantly more synovial thickening than APOε3 mice (125% increase; P = 
0.004). Furthermore strongly enhanced cartilage damage (18% increase; P = 0.019) and 
ectopic bone formation (an average of 160% increase) was observed in APOε4 mice 
compared to APOε3 mice. 
Conclusions 
Mice with the human APOε4 gene develop a more severe inflammatory OA compared to 
mice with the human APOε3 gene, suggesting a possible role of APOE polymorphisms in 
human OA development.  
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Introduction 
Osteoarthritis (OA) is a debilitating disease with a high worldwide prevalence. Although 
changed biosynthesis by chondrocytes, leading to extracellular matrix and eventually 
cartilage damage, is seen as the most important factor for initiating the disease
1
, interplay 
with the synovium is undeniably important for aggravation of OA pathology
2
. Previously, we 
have shown that synovial macrophages are important in different OA processes such as 
inflammation
3
, cartilage destruction
4
 and osteophyte formation
5
 during both human and 
experimental OA. Activated synovial macrophages are major producers of damage-
associated molecular patterns S100A8 (myeloid-related protein-8) and S100A9 (myeloid-
related protein-14). These so-called alarmins are released in large amounts upon synovial 
activation, aggravating joint inflammation
6
 and playing a pivotal role in the development of 
osteoarthritis
7
. 
Apart from pro-inflammatory factors, synovial macrophages also release anti-inflammatory 
factors, thereby controlling synovial activation. Apolipoprotein E (APOE) is such a protein 
which is produced in high amounts by the liver, but also by macrophages
8
. Macrophage-
activation strongly upregulates APOE production. Although this class of apolipoprotein was 
initially recognized for transporting lipoproteins and thereby promoting cholesterol 
metabolism, it has, more recently, also shown to play an important role in immunity
8
. APOE 
can modulate innate immunity by suppressing production of proinflammatory cytokines
9
, 
as well as by inhibiting oxidation of low-density lipoproteins (LDL), thereby preventing 
formation of pathogenic oxidized LDL
10
. Furthermore, APOE-signaling via the very low 
density lipoprotein receptor and APOE-receptor 2 has shown to promote macrophage 
conversion from the pro-inflammatory M1-like to the anti-inflammatory M2-like 
phenotype
8
. In humans, three polymorphisms of APOE exist, namely APOε2, APOε3 and 
APOε4, which have different efficacies in suppressing innate immunity (ε2>ε3>ε4).
9
 In light 
of this immunomodulating function of APOE, specifically the APOε4-genotype has been 
associated with inflammatory diseases such as atherosclerosis, Alzheimer’s disease and 
multiple sclerosis
11,12
. Since innate immunity also plays an important role in OA-pathology, 
we investigate in this concise report the role of APOε4 in experimental OA using mice with 
targeted homozygous replacement of the endogenous mouse APOE-gene by the human 
APOε3 or APOε4 gene. 
Methods 
Animals 
Twelve weeks old female B6.129P2-Apoe
tm2(APOE*3)Mae
N8 (APOε3) and B6.129P2-
Apoe
tm3(APOE*4)Mae
N8 (APOε4) targeted replacement mice, obtained from Taconic (Hudson, 
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NY, USA), were held in filter-top cages and received food and water ad libitum. OA was 
induced by intra-articular injection of 1 unit bacterial collagenase (Sigma-Aldrich, St. Louis, 
MO, USA) into the right knee joint on day 0 and day 2. Serum was obtained for colorimetric 
determination of cholesterol and mice were sacrificed on day 42, after which knee joints 
were collected for histology. This study was approved by the Institutional Review Board 
(Animal Experiment Committee Radboud University) and was performed according to the 
related codes of practice. 
Histology 
Tissue was fixed in 4% buffered formalin, decalcified in formic acid and embedded in 
paraffin. Eight representative sections (7 μm) of various depths per joint were mounted on 
glass slides and stained with H & E or Safranin O-fast green for histological analysis. Glass 
slides were coded and scored in a blinded way. Synovial thickening was measured using an 
arbitrary scoring system (0 = no synovial thickening; 1 = lining of two cell layers; 2 = more 
than 2 cell layers; 3 = clear inflammation with cell infiltrate or exudate). Cartilage damage in 
the tibial-femoral joint was scored using the Pritzker OA score, adapted for mice (from 0 = 
no damage to 30 = maximal damage)
13
, and size of ectopic bone formation by digital image 
analysis (Leica Application Suite v4.1; Leica Microsystems, Wetzlar, Germany). The mean of 
three (synovial thickening, ectopic bone formation) or five (cartilage damage) sections was 
determined per knee joint. 
Statistics 
Differences in pathology between APOε3 and APOε4 mice were statistically tested using a 
Mann Whitney U test (synovial thickening, cartilage damage) or a student’s t-test (size 
ectopic bone formation). All analyses were performed using Graph Pad Prism 5 (GraphPad 
Software, La Jolla, CA, USA). Data are depicted as mean ± 95% confidence interval. 
Results 
To investigate whether different human APOE-isoforms can affect OA pathology, we used 
APOε3 and APOε4 transgenic mice. Under normal conditions and a conventional diet, these 
mice have no abnormal plasma cholesterol levels
14
. In line with that, we found no 
differences in cholesterol levels between the two groups in this study (figure 1). 
Histological analysis of naïve knee joints from both APOε3 and APOε4 transgenic mice 
showed no abnormalities at the age of 12 weeks compared to WT mice and, in particular, 
there was no difference in synovial thickness, reflecting inflammation, between the two 
strains (figure 2A). 
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FIG 1. APOε3 and APOε4 mice show comparable levels of total cholesterol and LDL cholesterol 
Serum of both groups was analyzed for total cholesterol (A) and LDL-cholesterol (B) concentrations. n 
= 10 mice per group; data are presented as mean ± 95% confidence interval. 
Inflammatory OA was induced by injection of collagenase into the knee joint and, 42 days 
later, thickening of the synovial lining layer in APOε4 mice was significantly enhanced when 
compared to APOε3 mice (125% increase, from 0.8 to 1.8; figure 2B and D). At day 42, OA 
pathology was evident and comparable to our regular OA model in C57Bl/6 mice and 
resulted in a moderate-severe score for cartilage damage between 10 and 20 (on a scale of 
30). At the lateral site of the tibia,  APOε4 mice had 45% more cartilage damage compared 
with APOε3 mice (16 and 11, respectively; P=0.004). An increase in cartilage damage was 
also seen in the lateral side of the femur and both the medial side of both the tibia and 
femur, resulting in a 18% higher total score for cartilage damage in APOε4 mice compared 
with APOε3 mice (13 and 11, respectively; P=0.019; figure 2C and D). Also on ectopic bone 
formation, a third hallmark of OA, we found differences between APOε3 and APOε4 mice. 
The size of ectopic bone was scored on six different locations using digital image analysis 
(figure 3B). All six locations showed increased ectopic bone size in APOε4 mice in 
comparison with APOε3 mice with an average fold increase of 2.6. In particular, the lateral 
(39397 μm
2
 versus 7736 μm
2
) and medial (16974 μm
2
 versus 5739 μm
2
) side of the femur 
and the medial side of the tibia (264702 μm
2
 versus 111676 μm
2
) showed significantly 
more ectopic bone formation in APOε4 mice (figure 3A and C).  
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Discussion 
This brief report is the first to describe an effect of APOE polymorphisms on OA pathology. 
Differences between APOε3 and APOε4 in the ability to suppress innate immunity have 
been reported and are associated with several diseases in which innate immunity plays a 
role
11,12
. 
 
FIG 2. APOε4 mice show increased synovial thickening and cartilage destruction in comparison to APOε3 
mice during experimental OA 
Naïve knee joints of both groups show no significant synovial thickening (A). Forty-two days after 
induction of OA, APOε4 mice had more synovial thickening (B) and cartilage damage (C) compared to 
APOε3 mice. Panel D shows representative photomicrographs of synovial thickening and cartilage 
damage. n = 4 mice per group for naïve joints and n = 10 mice per group for OA knee joints; data are 
presented as mean ± 95% confidence interval. 
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FIG 3. During experimental OA, APOε4 mice have more ectopic bone formation compared with APOε3 
mice 
Panel A depicts trans-sectional size of ectopic bone using digital image analysis on the six locations 
illustrated in panel B. Panel C shows two representative photomicrographs of the medial site of the 
knee joint. Lig. = ligament; n = 10 mice per group; data are presented as mean ± 95% confidence 
interval. 
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In this study, we used an experimental model for osteoarthritis, characterized by synovial 
inflammation-mediated joint pathology, to show that different isoforms of APOE affect the 
disease outcome. Our data show that mice in which the murine APOE is replaced by human 
APOε4 develop a more severe OA compared with mice that have murine APOE replaced by 
APOε3. Since innate immunity plays an important role in OA pathology
3,4
 and APOE acts as 
a immunosuppressive protein
8-10
, the lack of immunosuppressive capacity of human APOε4 
could be an explanation for the increased pathology we observed. Even though, at this 
time, we merely focus on histological data from an experimental model, it gives us the first 
evidence to support the hypothesis that specific APOE polymorphisms in patients with 
inflammatory OA affect disease outcome. 
Since, in this study, we only compare two groups (APOε3 and APOε4) with each other, we 
cannot draw any conclusions on whether APOε4 is aggravating pathology, or APOε3 is 
protective against OA pathology. Although the in literature discussed mechanism of APOε3 
inhibiting innate immune processes more efficiently than APOε4
8,9
 would suggest the first, 
this will be difficult to prove in the present in vivo system. Proper control groups for this 
specific question would be hard to find since the use of WT mice would only show 
differences between human and murine APOE and the use of APOE-deficient mice would 
lead to all sorts of additional pathology due to increased systemic cholesterol levels
15
. 
In our opinion, discussing these preliminary data is an important first step in identifying the 
APOE molecule and its different isoforms as potential player in OA pathology. Even though 
the exact impact of different APOE-isoforms on OA is yet to discover, this brief report hints 
towards a possible role for APOε4 in human OA development and posits the APOE-
genotype as a new risk factor for this disease. The next important step would be to test 
APOE-polymorphisms in patients with inflammatory OA and investigate whether these 
polymorphisms are associated to a specific pathology independently of co-morbidities such 
as atherosclerosis and Alzheimer’s disease. Additionally, where we only focus in this study 
on disease severity and not on disease initiation, it would be of interest to investigate 
whether the APOε4-genotype would give a higher chance to develop inflammatory OA 
compared with the APOε3 or APOε2-genotype, using human cohort studies. 
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Chapter 7 
 
Summary and final considerations  
  
115 
 
Osteoarthritis (OA) is the most common rheumatic disease, affecting approximately 1.5 
million people in the Netherlands. Inflammatory processes have now shown to play a key 
role in OA development as they do in a plethora of diseases. Regardless of the vast amount 
of knowledge about the role of cholesterol in the pathology of inflammatory disorders such 
as atherosclerosis and despite increasing evidence that there is a relation between 
cholesterol levels and osteoarthritis development, cholesterol has gained relatively little 
attention in clinical OA research. The goal of this thesis was to establish a role for low-
density lipoproteins (LDL; commonly referred to as “bad cholesterol”), and specifically 
oxidized LDL (oxLDL), in OA pathology. Chapter 1 provides background information on 
osteoarthritis and its relation to cholesterol. Furthermore, we defined our hypothesis on 
how specifically oxLDL could aggravate OA pathology. Under inflammatory conditions and 
when free radicals are present, LDL could be oxidized. While LDL is mainly taken up by the 
LDL-receptor, OxLDL is taken up by scavenger receptors, which lack a regulatory 
mechanism for cell surface expression, resulting in accumulation of oxLDL in synovial 
macrophages, fibroblasts and endothelial cells. These synovial cells are then triggered and 
start to produce inflammatory factors, catabolic enzymes and growth factors, leading to OA 
pathology (see figure of chapter 1). 
In Chapter 2 of this thesis we found that both mice receiving a cholesterol-rich diet and 
mice with genetically enhanced cholesterol levels had increased ectopic bone formation 
during experimental OA. We found in vitro that stimulation of macrophages specifically 
with oxidized LDL led to activation of the TGF-β signaling pathway, which is a key driver of 
ectopic bone formation. Ectopic bone formation and cartilage destruction are main 
pathological outcomes of OA, and their development is related to synovial inflammation. 
Although, we did not find effects of high cholesterol levels on cartilage damage, we did 
observe an increased production of S100A8 and S100A9 in the synovial lining of animals 
with high levels of cholesterol during OA, which is a indication of synovial activation. These 
observations, together with massive APOB accumulation in the synovium of Ldlr
-/-
 mice and 
mice on a cholesterol-rich diet, suggest that high cholesterol levels during OA lead to 
increased presence of oxLDL and S100A8/A9 in the synovium, indirectly shifting joint 
homeostasis toward an exaggerated anabolic state causing pathology. 
Chapter 3 addresses the relation between S100A8/A9 production and osteophyte 
formation to a greater extent. In this chapter, we showed that mice deficient for S100A8 
and S100A9 developed less ectopic bone compared to wild type mice during inflammatory 
OA. The fact that this difference in ectopic bone formation was not seen in a less 
inflammatory and more mechanical model for OA underlines the importance of synovial 
cells in this process. We did not only focus on murine models in this chapter, but also 
investigated the effects of systemic S100A8/A9 levels on ectopic bone formation in early 
116 
 
OA patients. In these patients we also found a relation between S100A8/A9 levels and 
ectopic bone formation; patients with S100A8/A9 plasma concentrations higher than 200 
ng/mL had significantly more chance to develop ectopic bone 2 years later (odds ratio 4.0). 
Subsequently, in vitro cultures gave us a possible mechanistic relation, as we found that 
S100A8 activated catabolic factors in micromasses created with mesenchymal stem cells, 
particularly matrix metalloproteinase 3 (MMP3). These data suggest that increased 
S100A8/A9 levels could result in MMP3-mediated remodeling of cartilage during 
osteophytosis, therefore allowing for more severe ectopic bone to form during OA. 
In Chapter 4, we focused again on high cholesterol levels. We used Apoe
-/-
 mice and mice 
on cholesterol-rich diet and we not only confirmed enhanced ectopic bone formation by 
high cholesterol at end-stage experimental OA, but also demonstrated that high cholesterol 
levels led to early onset of ectopic bone formation. Furthermore we found increased 
synovial inflammation (characterized by increased synovial thickening, chemokine CXCL1 
upregulation and S100A8/A9 production). Since these data confirmed a relation between 
high cholesterol levels, S100A8/A9 production and ectopic bone formation, the question 
arose whether ectopic bone formation was mainly accomplished via TGF-β activation or via 
S100-mediated cartilage remodeling. We therefore used mice deficient for both APOE and 
S100A8/A9. Thirty-six days after induction of OA, these Apoe
-/-
S100a9
-/-
 mice showed 
comparable ectopic bone formation to mice only deficient for APOE, suggesting that 
cholesterol-induced ectopic bone formation during OA is not essentially mediated by 
S100A8/A9. We did, however, observe a decrease in chemokine-production in Apoe
-/-
S100a9
-/-
 mice, suggesting an important role for S100A8/A9 in synovial inflammation during 
OA. 
In Chapter 5 we put more emphasis to the mechanism by which cholesterol could afflict 
earlier observed joint pathology and specifically which element of the cholesterol pathway 
was responsible for this. We tested our above mentioned hypothesis (extensively discussed 
in the first chapter) by injecting oxLDL and LDL directly into naïve murine knee joints and 
found that specifically injection of oxLDL, not native LDL, resulted in activation of the TGF-β 
signaling pathway. This confirmed our hypothesis that cholesterol-mediated ectopic bone 
formation during OA could be the result of synovial stimulation by oxLDL. Remarkably, we 
did not find increased production of S100A8/A9 or other signs for synovial activation after 
injection of oxLDL. An explanation may be that the relatively low amounts of LDL/oxLDL 
that we were able to inject into the mouse knee joint, in comparison to the high LDL levels 
found in Ldlr
-/-
 and Apoe
-/-
 mice, was simply scavenged by lining macrophages and cleared 
from the system. We therefore selectively depleted the synovial lining of macrophages by 
injection of clodronate liposomes, preceding injections of oxLDL. Interestingly, in absence 
of lining macrophages, injections of oxLDL led to production of S100A8/A9 (comparable to 
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what we found in chapter 2 and 4), chemokine production and influx of monocytes and 
neutrophils. Activation of TGF-β signaling was not found at this time, however, we did find 
early signs of cartilage damage in the form of cartilage neo-epitopes (NITEGE), which 
remain in the cartilage matrix after aggrecanase-mediated breakdown of matrix 
constituents. Again, native LDL was not able to induce these effects. Moreover, natural high 
levels of cholesterol with no underlying inflammation (naïve Apoe
-/-
 mice) did not show any 
of these effects both with lining macrophages present and absent. Our results suggest that 
oxLDL in the synovium can stimulate both macrophages as well as fibroblasts/endothelial 
cells, both resulting into different processes. OxLDL stimulates macrophages to release 
anabolic factors such as TGF-β, whereas fibroblasts and endothelial cells are stimulated to 
produce chemokines which attract inflammatory cells, thereby promoting cartilage 
destruction. This further underlines that specifically oxidized LDL is an important factor in 
cholesterol-mediated joint pathology as summarized in the figure below.  
 
Synovial stimulation with oxLDL aggravates OA pathology 
Stimulation of macrophages by oxLDL during OA results in production of TGF-β, which induces ectopic 
bone formation and reverses cartilage damage. In the absence of macrophages, or in situations when 
excessive amounts of oxLDL are present, oxLDL is taken up by fibroblast and endothelial cells. These 
cells then start to produce chemokines, leading to inflammation and cell influx. Inflammation leads to 
cartilage damage and S100A8/A9 production, facilitating bone remodeling and further promoting 
cartilage damage. Inflammatory conditions accelerate LDL-oxidation, resulting in a vicious cycle, 
aggravating OA pathology. 
 
In this thesis, we mainly focus on LDL and oxLDL itself. There are, however, many factors 
that have effect on the availability and balance of LDL and its oxidized form, which could 
also have consequences for OA pathology. An important molecule involved in the transport 
of LDL is APOE, which is the focus of Chapter 6. The main function of APOE is transporting 
cholesterol and lipoproteins into the lymph system and blood. APOE is, however, also 
implicated in several immunological processes such as activation and proliferation of 
lymphocytes, platelet aggregation, peroxidation of lipids and oxidation of LDL. Different 
polymorphisms of this molecule exist in humans (APOε2, APOε3 and APOε4) and these 
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specific isoforms have been implemented in the severity of inflammation-related diseases 
(e.g. atherosclerosis, multiple sclerosis and Alzheimer’s disease) due to their varying 
efficacy in performing above mentioned functions. APOE is generally accepted as an anti-
inflammatory molecule, inhibiting innate immune responses. This anti-inflammatory 
capacity, however, differs per isoform (ε2>ε3>ε4). In this brief chapter we showed that the 
isoform of APOE could indeed affect OA pathology. Mice with the human APOε4 gene 
presented with more severe inflammation, cartilage damage and ectopic bone formation 
during experimental OA compared with mice with the human APOε3 gene, implicating 
APOE-isoform as a possible OA risk factor. 
Overall, a relation between cholesterol and OA-severity seems evident. Although the data 
described in this thesis are mainly based on murine models, one can reasonably assume 
that some of the described mechanisms could also be extrapolated to the human situation 
since mice mirror the human biology in many respects. Known risk factors for OA in 
humans such as high cholesterol levels and increased oxidative stress support the idea that 
oxidized LDL also plays an important role in the etiopathology of this disease in humans. 
From this thesis we could conclude that, in the joint, high levels of LDL in combination with 
inflammation is important for OA pathology via formation of oxLDL. This knowledge offers 
new insights into possible therapies. Systemic statin treatment in combination with local 
administration of anti-oxidants could lower LDL levels and, at the same, time diminish 
oxidation of LDL in the joint. Local LDL levels could also be lowered by injecting proprotein 
convertase subtilisin/kexin type 9 (PCSK9) inhibitors, which increases LDL uptake by LDL 
receptors. Furthermore, blocking oxLDL-uptake by scavenger receptors with specifically SR-
A antagonists, CD36-blocking peptides or soluble LOX-1 could be an even more effective 
therapy, making it possible to switch specific pathways for oxLDL-uptake on or off. The data 
presented in this thesis and future research into the relation between cholesterol and joint 
pathology could be an important foundation for our understanding of OA pathology and 
could form a basis for possible future treatment of this so far incurable disease.  
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NEDERLANDSE SAMENVATTING 
Artrose, oftewel osteoartritis (OA), is een van de meest voorkomende reumatische 
aandoeningen wereldwijd. In Nederland alleen zijn er ongeveer 1,5 miljoen mensen door 
deze ziekte aangedaan. Het wordt steeds duidelijker dat, zoals ook bij vele andere ziekten, 
ontstekingsprocessen een sleutelrol spelen bij de ontwikkeling van artrose. Daarnaast is er 
veel onderzoek gedaan naar de rol die cholesterol speelt in inflammatoire ziekten (ziekten 
waarbij ontsteking een belangrijke rol speelt) zoals atherosclerose (aderverkalking). Er zijn 
steeds meer bewijzen dat er een verband bestaat tussen hoge cholesterolwaardes en OA. 
Desondanks wordt er relatief weinig aandacht besteed aan cholesterol in OA-onderzoek. 
Het doel van dit proefschrift was het vaststellen wat de rol voor lage-dichtheids-
lipoproteïnen (LDL), het zogenoemde ‘slechte cholesterol’, en de geoxideerde vorm van 
deze LDL (oxLDL) zou zijn in het OA-ziektebeeld. Hoofdstuk 1 bevat achtergrondinformatie 
over OA en de relatie tussen deze ziekte en cholesterol. Verder formuleren we in dit 
hoofdstuk een hypothese over hoe LDL, en in het bijzonder de geoxideerde vorm, artrose 
kan verergeren door het activeren van immuuncellen in het gewrichtskapsel (synovium). 
In Hoofdstuk 2 van dit proefschrift vonden we dat zowel muizen die een cholesterol-rijk 
dieet kregen, als muizen die van nature hoge cholesterolwaardes hadden tijdens OA een 
ernstiger ziektebeeld vertoonden. Deze muizen ontwikkelden extra botvorming in het door 
artrose aangedane gewricht op plekken waar dit niet hoorde, ook wel ectopische 
botvorming genoemd. Deze ectopische botvorming leidt bij mensen tot pijn en 
functiebeperking van het gewricht. We vonden verder dat stimulatie van specifieke 
synoviale immuuncellen (macrofagen) met oxLDL leidde tot activatie van signaleringsroutes 
van groeifactoren die verantwoordelijk zijn voor ectopische botvorming. Bovendien bleek 
dat muizen met verhoogde cholesterolwaarden een geactiveerd synovium vertoonden, wat 
suggereert dat er inderdaad in dit model een relatie is tussen hoge cholesterolwaarden en 
verergering van OA. 
In Hoofdstuk 3 zijn we dieper ingegaan op de relatie tussen geactiveerd synovium en 
ectopische botvorming. We vergeleken in dit hoofdstuk normale muizen met muizen die 
belangrijke synoviale activeringseiwitten misten (namelijk de eiwitten S100A8 en S100A9) 
en keken hoe ectopische botvorming zich tijdens OA in deze muizen ontwikkelde. Wat we 
zagen was dat muizen waar synoviale activatie door het missen van S100A8 en S100A9 
(S100a9
-/-
) laag was, minder ectopische botvorming vertoonden dan normale (wildtype) 
muizen. Naast diermodellen onderzochten we in dit hoofdstuk ook het bloed van patiënten 
met beginnende OA en vergeleken dit met de mate van ectopische botvorming in diezelfde 
patiënten twee jaar later. Wat we vonden was dat hoge S100A8/A9 waardes in het bloed 
bij patiënten voorspellend waren voor het ontwikkelen van ectopische botvorming, wijzend 
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op een verband tussen S100A8 en S100A9 en botvergroeiingen. Dit werd verder benadrukt 
door onderzoek met behulp van stamcellen die werden uitgegroeid tot kraakbeen, waar we 
vonden dat S100A8 remodellering van het kraakbeen stimuleerde.  
In Hoofdstuk 4 richtten we ons weer op hoog cholesterol. We gebruikten muizen die 
vanwege een genetische modificatie hoge cholesterolwaarden ontwikkelen (Apoe
-/-
) en 
bevestigden onze eerdere observaties dat deze muizen tijdens OA meer ectopische 
botvorming vertonen dan normale (wildtype) muizen. Niet alleen vonden we dat er meer 
ectopische botvorming was, maar ook dat deze ontwikkeling eerder in het ziekteproces tot 
uiting komt. Ook in deze studie vonden we verhoogde productie van de eiwitten S100A8 en 
S100A9. Om meer te weten te komen over de relatie tussen cholesterol, S100-eiwitten en 
ectopische botvorming, werd vervolgens OA opgewekt in muizen die zowel de cholesterol-
verhogende genetische modificatie bevatten en niet in staat waren tot het aanmaken van 
de S100A8 en S100A9 eiwitten (Apoe
-/-
S100a9
-/-
). Uit dit experiment bleek dat de S100 
eiwitten niet verantwoordelijk zijn voor cholesterolgedreven ectopische botvorming, maar 
wel voor de cholesterolgedreven synoviale activatie en dus gewrichtsontsteking. 
Hoofdstuk 5 legt de nadruk vooral op het mechanisme waarop LDL (‘het slechte 
cholesterol’) en geoxideerd LDL (oxLDL) direct schade kunnen aanrichten in het 
kniegewricht. We injecteerden LDL en oxLDL direct in het gewricht van gezonde muizen en 
observeerden dat oxLDL, maar niet LDL, in staat was signaalroutes van groeifactoren te 
activeren, overeenkomstig met de indirecte bevindingen uit hoofdstuk 2. Gezien onze 
hypothese dat deze activatie voornamelijk te wijten was aan één specifiek celtype in het 
synovium, namelijk de macrofaag, was de volgende stap het verwijderen van macrofagen 
uit het gewricht. In afwezigheid van macrofagen leidde injecties van oxLDL niet meer tot 
activatie van groeifactoren maar tot productie van S100A8 en S100A9. Verder vonden we 
een vroege vorm van kraakbeenschade en ontsteking in het synovium. Ook hier, in 
afwezigheid van macrofagen, was gewoon LDL niet in staat deze effecten teweeg te 
brengen. Deze data bevestigen dat cholesterolgedreven pathologie in het gewricht 
waarschijnlijk het gevolg is van verhoogde opname van oxLDL door synoviale cellen, maar 
dat de soort pathologie afhankelijk is van het type cel dat in contact komt met oxLDL. 
Hoewel we in dit proefschrift voornamelijk de nadruk leggen op LDL en oxLDL, zijn er vele 
andere aspecten in de cholesterolhuishouding die een rol kunnen spelen in de ontwikkeling 
en de ernst van artrose. Eén voorbeeld, en het onderwerp van Hoofdstuk 6, is het APOE-
molecuul. Hoewel dit molecuul voornamelijk verantwoordelijk is voor het transport van 
cholesterol, laat recente literatuur zien dat het ook immunologische effecten kan 
beïnvloeden. Mensen kunnen verschillende vormen van APOE hebben en deze 
verschillende vormen zijn in verband gebracht met de ernst van ziekten waar het 
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immuunsysteem een belangrijke rol speelt zoals atherosclerose, MS en Alzheimer. In dit 
korte hoofdstuk vergeleken we de ernst van OA in muizen met verschillende vormen van 
het menselijke APOE-molecuul en observeerden voor het eerst dat het type APOE 
inderdaad effect heeft op het ziektebeeld en dat het APOE-isotype gezien kan worden als 
mogelijke risicofactor voor OA. 
Concluderend kunnen we stellen dat er een relatie bestaat tussen cholesterol en de ziekte 
artrose. De data die in dit proefschrift beschreven worden kan basis zijn voor het ontrafelen 
van de oorzaak van OA en ten grondslag liggen aan nieuwe therapieën voor deze -tot nu 
toe- ongeneeslijke ziekte. 
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